MBA Program in
Health Care Management
2024
Wharton
RESUME
BOOK
Contents
Program Description ............................4
Curriculum ....................................5
Graduates ..................................6-29
Internship Sponsors........................... 30
Administration ................................31
Health Care Program Mentors ............... 32-33
Faculty................................... 34-35
Thank you for your interest in the Wharton MBA Program
in Health Care Management. For further information,
resumes, and appointments, contact:
June Kinney, Director,
MBA Program in Health Care Management
The Wharton School
University of Pennsylvania
3641 Locust Walk
Philadelphia, PA 19104-6218
215.898.6861
For information on the Wharton Health
Care Management Alumni Association, visit
www.whartonhealthcare.org
For detailed information on the Health Care
Management Department educational programs,
visit http://mba.wharton.upenn.edu/healthcare
MBA Graduates
The University of Pennsylvania was founded by
Benjamin Franklin in 1740. Although the University
carries the name of the Commonwealth, it is not
a state university but an independent, private, non-
sectarian institution. As one of the country’s earliest
educational institutions, it has consistently initiated
advances in teaching and research and has steadily
generated specialized fields of higher education.
Penn, as the University is commonly known, was the
first American university to form departments of
botany, hygiene and public health, surgical research,
and research medicine. The University School of
Medicine, formed in 1765, was the first in North
America, as was the teaching hospital founded in
1874. The world’s first psychological clinic was
opened at Penn in 1896.
The Wharton School, in the same spirit of
innovation and excellence, was the world’s first
collegiate school of business and management.
Founded in 1881 with a gift from Joseph Wharton,
the Philadelphia industrialist and philanthropist, the
Wharton School undertook the pioneer steps in
elevating training for business significantly above its
previous level as noncollegiate commercial education.
In 1921, the formation of the Graduate Program
signaled the advancement of business administration
at Wharton to the highest levels of professional
education.
Today, the Wharton School has more than 480
faculty members teaching in both the graduate and
undergraduate divisions and conducting a continually
expanding volume of research. The 1,785 students
in the master’s degree program may choose from
among more than 200 courses and over 19 majors
and concentrations, a variety reflecting the fact that
the Wharton education complements the career
goals of the individual.
This brochure is provided to introduce you to the
2024 Wharton Health Care Management Program
graduates.
We encourage you to consider these individuals
for employment.
2024
Health Care Management
3
4
The Graduate Program in Health Care Management
is a full-time 2-year MBA curriculum offered by
the Health Care Management Department of
the Wharton School. The program, the principal
educational effort at the Leonard Davis Institute of
Health Economics, is designed to provide managerial
and technical expertise to students interested in
the health care management field. By combining the
skills of the Wharton disciplines with sensitivity to
the needs of health care providers and recipients,
the Wharton MBA health care graduate can
effectively manage the delivery of health services
and products at all levels.
The Program has produced graduates who have
chosen careers in hospitals and other medical
institutions, pharmaceutical, biotechnology and
medical device companies, digital health care,
financial services, entrepreneurial ventures,
consulting firms, insurance firms, private health
industry, and federal, state, and local government.
Many of these MBA graduates now hold positions
as chief executive officers, directors, and other
key decision makers in health care organizations.
The Leonard Davis Institute of Health Economics
(LDI) is an interdisciplinary center for research
and education in the organization, financing,
and delivery of health care. Through LDI, University
of Pennsylvania faculty and staff work together
on issues concerning health policy, health insurance,
managed care, hospitals, corporations, pharmaceutical
companies, and other health-related organizations.
Established in 1967, the Institute appropriately bears
the name of the late Leonard Davis, one of the
foremost innovators in private health insurance in the
United States. He was the founder of Colonial Penn
Group, Inc., a company that has pioneered in insurance
for older Americans. Both Mr. Davis and Mrs. Sophie
Davis were generous benefactors to the University
of Pennsylvania, contributing basic support for the
activities of the Leonard Davis Institute.
Program Description
5
All students are required to complete the Wharton Management
Core. The Wharton School’s core curriculum is designed to increase
crossfunctional integration, extend global experience, strengthen
leadership training, and introduce new courses on key management
issues. The core curriculum provides groundwork in basic management
disciplines: economics, finance, financial and cost accounting,
management science, managing people and organizational design,
marketing, operations management, the governmental and legal
environment of business, statistics, and strategy.
Fixed Core:
• Leadership: Foundations of Teamwork and Leadership
• Marketing: Marketing Management
• Microeconomics: Microeconomics for Managers
• Microeconomics: Advanced Microeconomics for Managers
• Statistics: Regression Analysis for Managers
• Management Communication: Speaking and Writing
Flexible Core:
Operations, Information, and Decisions Options:
• Quality and Productivity
• Business Analytics
• Enabling Technologies
• Innovation
• Managerial Decision Making
• Operations Strategy
Marketing Options:
• Dynamic Marketing Strategy
• Strategic Marketing Simulation
Communications Options:
• Impromptu Speaking and Elements of Story for Business
• Crisis Communication
• Fundamentals for Prospective Entrepreneurs
• Advanced Persuasive Speaking
• Communications Challenges for Entrepreneurs
• Persuasive Writing for Business Leaders
Accounting Options:
• Financial Accounting
• Financial and Managerial Accounting
Corporate Finance Options:
• Corporate Finance
• Introduction to Corporate Finance
Macroeconomics Options:
• Macroeconomics
• Introduction to Macroeconomics
Management Options:
• Managing the Established Enterprise
• Managing the Emerging Enterprise
Legal Studies & Business Ethics
• Responsibility in Global Management
• Responsibility in Business
• Business, Social Responsibility, and the Environment
International Programs:
Global Modular Courses: Short full-credit courses in an intensive
workshop format in a country relevant to the topic.
Global Immersion Program (GIP):
A high-level survey of the economic, cultural, and geo-political
drivers behind regions integral to the global economy. Students
then experience it in-country.
The Health Care Major Courses and Electives:
These courses promote an understanding of concepts,
institutions, and issues involved in the organization,
financing, and delivery of health services and products
in the United States and globally. Health care electives are
selected consistent with individual career objectives and interests.
Required
• Introduction to Health Management
• Health Care Field Application Project
Electives
• US Payer and Provider Strategy
• Health Care Reform and the Future of the
American Health System
• Health Care Services Delivery:
A Managerial Economic Approach
• Management and Strategy in Medical Devices
and Technology
• Management of Health Care for the Elderly
• Healthcare Data and Analytics
• Comparative Health Care Systems
• Leading Health Care Organizations
• Management & Economics of Pharmaceutical
and Biotechnology Industries
• The Digital Transformation of Healthcare
• Health Care Entrepreneurship
• Private Sector Development in Global Health Development
• Business of Behavioral Health
• Advanced Study Project Seminar:
Management of Health Service Businesses
The Health Care Summer Internship
The internship is a 3-month management experience that provides
the health care major an opportunity to work with a senior
executive in an organization of particular interest to the student.
MBA Electives
Opportunities are available for the health care major to pursue
a second concentration in fields such as entrepreneurship,
marketing, finance, or operations, or to pursue specialized
knowledge in areas such as health care financing or within
specialized segments of the health care industry including
health plans, hospitals, pharmaceutical and biotechnology
companies, medical device companies, specialty services
organizations, and long term care organizations. Graduate
courses are available throughout the University.
Curriculum
The Wharton Management Core
6
Edward J. Bae
Georgetown University, Washington, DC
B.S., Health Care Management & Policy, 2016
An opportunity to improve provider
enablement through diversification to
create a cohesive care journey that
will reduce costs and improve patient
outcomes.
Goldman Sachs, New York, NY
Investment Banking Summer Associate,
Summer 2023
Supported 2 live transactions: a divestiture
of a ~$100B MedTech company and a
$2.8B pharma strategic partnership and
created two pitchbooks on inorganic
growth strategies for a $20B MedTech
and a $15B diagnostics company.
Horizon Blue Cross Blue Shield, Newark, NJ
Corporate Development & Strategy
Manager, 2020-2022
Corporate Development & Strategy Senior
Analyst, 2019-2020
Advised c-suite and board of directors
on key strategic issues including
corporate strategy, growth strategy,
value creation and corporate
development initiatives; regularly
worked directly with and presented
to Horizon executives.
CareCentrix, New York, NY
Strategy Analyst, 2018-2019
Accelerated partnership development by
leading business development initiatives
(Request for Proposal opportunities),
go-to-market strategies and structuring
deals with health plans and systems;
sole analyst on a 5-member growth
strategy team.
Mount Sinai Hospital, New York, NY
Analyst, 2016-2018
Led strategic initiatives throughout the
Primary Care Institute (PCI) and advised
due diligence and sourcing in venture
capital / strategic investments for Mount
Sinai Ventures; sole analyst of a
3-person team.
Maryam M. Alausa
University of Pennsylvania, Philadelphia, PA
B.A., Magna Cum Laude Health and Societies,
2019; Perelman School of Medicine at the
University of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2024
An opportunity to blend my clinical
experience and acumen with my passion
for innovation to manage and scale
healthcare delivery systems.
McKinsey & Company, Chicago, IL
Associate Consultant, Summer 2023
Collaborated with a federal govt agency
to identify vulnerabilities in taxpayer-
sponsored health insurance related to
fraud, waste, and abuse. Spearheading
a comprehensive analysis, I uncovered
83 critical vulnerabilities affecting
access to care and devised a plan for
pilot testing and investigations.
Snider Consulting, Venture Lab,
Philadelphia, PA
Consultant, 2022-2023
Conducted research to evaluate the market
potential for a medical device for go-to-
market strategy. Collaborating with fellow
consultants, we conducted a valuation
analysis for a medical device startup along
with a comprehensive go-to-market strategy.
Perelman School of Medicine,
Philadelphia, PA
Clinical Rotation, 2020-Present
Collaborated with a medical team,
actively participating in the development
of daily care plans for patients across
various medical specialties. I effectively
managed a rotating panel of up to four
patients, spanning Surgery, Emergency,
Neurology, Psych, and Internal Medicine.
Geisinger Health System, Danville, PA
Business Fellow, Summer 2020
Established and managed a strategic part-
nership aimed at delivering telehealth ser-
vices to an external multi-specialty health
system. Created a framework for future
telehealth strategic partnerships to a team
of 15 VPs. Developed an operational play-
book based on departmental data, strategy,
and past operational performance to
ensure institutional preparedness for a
potential COVID resurgence, providing valu-
able insights for health system and policy.
Vartika Agrawal
National Institute of Technology, Bhopal, India
B.Tech Bioinformatics, 2012
Georgia Institute of Technology, Atlanta, GA
MS, Bioinformatics, 2013
An opportunity to blend my scientific
background and business learnings to
bring innovation in precision medicine.
Boston Consulting Group, Seattle, WA
Summer Consultant, Summer 2023
Worked for a large commercial insurer
to identify $230M in annual cost savings
as part of an overhaul of the company’s
third-party spend and engagement with
third party administrators. Project work
included research into efficient payor
operations, analysis of ramifications
of vendor payment terms alterations,
presenting to BCG leadership, and advising
on implementation of proposed strategies.
10x Genomics, Pleasanton, CA
Product Manager, 2021-2022
Associate Product Manager, 2019-2021
Managed software and assay (reagents)
products for single cell genomic profiling
of biological cells. Responsible for P&L of
protein profiling product ($40M in annual
revenue) leading to 40% YoY revenue
growth and 20% customer growth. Led
launch of visualization software (Loupe
Browser) that aids immunology researchers
to screen antibodies based on antigen
binding; conducted customer interviews,
defined product requirements and
coordinated with team of 15+ engineers
and designers to launch product.
Philips Healthcare, Cambridge, MA
Research Scientist and Product Manager,
2014-2019
Conceptualized and developed algorithms
for genomic data analysis that led to 3
patent grants (4 additional filings) and
were incorporated into IntelliSpace
Genomics product – Philips’ first genomics
based clinical decision support product.
Led product development as part of
5-member incubator; defining product
requirements, conducting customer
interviews and collaborating with software
development teams across Israel,
Netherlands and India.
7
William H. Bartlett
Yale University, New Haven, CT
B.A., Distinction, History of Science and
Medicine, 2014
Georgia Institute of Technology, Atlanta, GA
M.S., Computer Science, 2020
An opportunity to make healthcare
more efficient.
Windham Venture Partners, New York, NY
Investment Intern, Summer 2023
Analyzed the healthcare artificial intelligence
sector to develop firm theses and make
investment recommendations, several of
which went on to the diligence phase.
Sourced, screened and performed diligence
on seed through series C health-tech
startups. Led a firm-sponsored webinar on
AI in healthcare for current and potential LPs.
ConcertAI, Boston, MA
Senior Data Scientist, 2021-2022
Managed 3 key large pharmaceutical
client accounts (totaling $10M+ in ARR)—
served as primary ConcertAI (CAI) scientific/
technical adviser for client projects involving
CAI real-world data products; identified
opportunities to drive client R&D objectives
with CAI products; collaborated with
product teams to implement product
updates based on client feedback. Led
applied machine learning projects to
identify novel predictors of cancer
treatment outcomes with real-world data.
Signify Health, New York, NY
Data Scientist, 2020-2021
Developed novel machine learning
methods to predict medical procedures
(episodes of care) from insurance claims
data resulting in improved identification
of future high care-utilizing patients.
Analyzed effects of operational performance
metrics on company savings (from
bundled payments).
Arjun Bakre
University of Michigan, Ann Arbor, MI
B.B.A., Finance, 2017
An opportunity to build and grow category-
defining healthcare and technology
businesses on the right side of change.
Juxtapose, New York, NY
Concept Development Intern,
Summer 2023
Developed and diligenced new con-
cepts at various stages in concept
development process. Supported
launch of healthcare newco.
Clayton, Dubilier & Rice, New York, NY
Sr. Director at apree health, 2022
Associate, 2019–2021
Investor on 50+ person investment
team, with personal focus on investments
in healthcare, tech-enabled services,
and industrials. Deal experience and
portfolio involvement includes agilon
health, apree health, Millennium
Physician Group, White Cap, and
Covetrus. Following time on CD&R’s
investment team, joined apree health
(formerly Vera Whole Health & Castlight
Health), to support business development,
anchor partnership implementation,
and broader strategy efforts.
Evercore, New York, NY
Analyst, 2017-2019
Analyst on Information & Media M&A
team focused on growth-stage technology
businesses. Sub-sectors included vertical
software, marketing services/tech,
adtech, and edtech.
Diksha Bahl
Lady Shri Ram College for Women, Delhi, India
Bachelor of Commerce, Summa cum laude, 2018
An opportunity to leverage my
operational and financial expertise to
improve access to quality healthcare by
growing healthcare services businesses.
The Cranemere Group, New York, NY
Summer Associate, Summer 2023
Advised CEO and COO of portfolio
companies on growth strategy, market
entry and sales acceleration; Outpatient
radiology service provider: Developed
inorganic growth strategy to double
revenue in 3 years, designed roadmap
to capture $7M additional EBITDA by
improving salesforce effectiveness;
Revenue cycle management player:
Enabled new market entry to capture
~20% EBITDA improvement (600+
employees hired in 2 months)
Boston Consulting Group, Delhi, India
Consultant & CEO Ambassador, 2018-2022
Helped scale BCG’s public health practice
in India; worked with providers,
governments, corporations and
philanthropies to improve access to
quality care by developing policies and
implementing systemic interventions
leveraging tech and processes e.g.,
strategized public health response to
Covid as part of Health Ministry’s war
room (launched tracking app for
6,000+ hospitals in 15 days, rolled out
upskilling program for 10,000+ clinicians)
W Health Ventures, Delhi, India
Summer Intern, Summer 2022
VC fund that set up India’s first healthcare
focused venture studio; developed
investment thesis on opportunity to
address sleep-disorders via digital-first
solutions.
8
Kavya Bodapati
University of Pennsylvania, Philadelphia, PA
B.A., Biology, 2016
An opportunity to improve health
outcomes through innovative digital
health products and care delivery
strategies.
Humana, Boston, MA
Product Manager, Summer 2023
Created feedback loop strategy
supporting launch of Virtual Cardiac
Rehab engagement study. Developed
technical and operational recommen-
dations for improving CenterWell new
patient outreach.
Stellar Health, New York, NY
Senior Manager, Strategic Operations, 2022
Strategic Operations Lead & Manager,
2020-2021
Spearheaded Stellar program deployment
within new customer segment. Managed
enterprise customer with 200,000+
patients; oversaw multi-million-dollar
staff incentives budget. Developed and
launched new pediatrics product. Managed
a team of 2 direct reports and served
on Operations Team leadership council.
RubiconMD, New York, NY
Clinical Strategy & Operations Manager, 2020
Implementation Manager, 2019-2020
Senior Implementation Associate, 2018-2019
Collaborated with Data Science to
develop standardized customer
dashboards. Advocated successfully for
hiring Account Management team and
served as interim Account Manager,
managing customers representing $1M+
in revenue (including Oak Street Health).
IQVIA, Plymouth Meeting, PA
Associate I-II, 2016-2018
Analyzed and translated clinical and
competitive landscape research into client
strategy for major disease areas for
clients’ assessing product acquisitions.
Conducted market research at international
medical conferences; synthesized readout
session content and interviewed key
opinion leaders to identify potential
impacts to clients’ portfolios.
Nina J. Bondre, CPO
Duke University, Durham, NC
B.S., Neuroscience, 2013
Northwestern University, Chicago, IL
Master of Prosthetics & Orthotics, 2015
An opportunity to leverage my health
care provider experience to support
underserved communities.
Medtronic, Minneapolis, MN
Innovation Lab MBA Intern, Summer 2023
Mapped customer ownership journey
via 29 stakeholder interviews to craft
recommendations for digital optimization.
Interviewed 4 designers to prototype
guidebook on design research method.
Ottobock Healthcare, Austin, TX
Education Specialist, 2022
Authored 2 e-Learning courses on
orthotic products (completed by 259
providers), 92% recommend these
courses to other clinicians. Designed 5
new hire onboarding courses for
Ottobock North America introducing
employees to foundational orthotic
and prosthetic concepts.
Cascade Orthopedic Supply, Chico, CA
Clinical Educator, 2019-2022
Crafted comparative analysis of
customer buying habits across 3,000
national accounts, allowing sales team
to tailor pitches. Formed Customer
Council to promote timely, critical
feedback on new product launches
and expansions.
Dankmeyer, Inc., Linthicum, MD
Certified Prosthetist Orthotist, 2015-2019
Provided orthoses, prostheses, and
clinical care to improve quality of life
for 1,500 patients, specializing in
pediatric and spinal cord injury care.
Strategized and implemented care
plans for 500 patients to address
multifaceted medical and social needs
by collaborating with Johns Hopkins
Hospital and Kennedy Krieger Institute
physicians and physical therapists
Naomi S. Bright
Massachusetts Institute of Technology,
Cambridge, MA
B.S., Chemical Engineering, 2019
An opportunity to build and scale
healthcare companies by coupling
innovative and strategic thinking with
effective implementation.
Boston Consulting Group, Philadelphia, PA
Summer Consultant, Summer 2023
Designed a new commercial organization
structure ahead of major product
launch to drive significant growth for a
biotech company.
Bristol Myers Squibb, New Brunswick, NJ
Associate Research Scientist, 2019- 2022
Optimized production process of small
molecule active pharmaceutical
ingredients and intermediates to improve,
yield, quality and process costs at lab
scale. Managed large scale production
with internal and external vendors.
9
Sarah E. Caldwell
Yale University, New Haven, CT
B.S., Biomedical Engineering, 2019
An opportunity to improve healthcare
access and create a sustainable workforce.
McKinsey and Company, New York, NY
Engagement Manager, Summer 2023
Supported McKinsey’s internal initiative
Mind Matters. Worked to ensure
resources are readily available to
support the mental health of colleagues
globally, and planned events and
campaigns for elevating the
conversation on mental health.
McKinsey and Company, New York, NY
Engagement Manager, 2019 - 2022
Worked in McKinsey’s Social Sector,
Healthcare, and Public Entities practice,
primarily supporting hospital systems
and government agencies on operations
and workforce management. Supported
crisis response and planning efforts
during the COVID-19 pandemic, workforce
planning amid the launch of 988
(Suicide & Crisis Lifeline), and executive
& senior leadership organization design
post hospital mergers.
Dan R. Burkhart
James Madison University, Harrisonburg, VA
B.B.A., Summa Cum Laude, Finance, 2016
An opportunity to build and invest in
businesses transforming healthcare.
T. Rowe Price, Baltimore, MD
Equity Analyst, Summer 2023
Analyzed public equities for $1.4T AUM
investment platform. Developed
differentiated views on business services
sector, leading to >$100M investment
in information services company.
Flexpoint Ford, Chicago, IL
Director of Strategic Projects / Corporate
Development for YPrime and Canadian
Hospital Specialties, 2022
Private Equity Associate, Healthcare, 2018-2021
Managed all aspects of investment
process for buyout opportunities in the
healthcare sector. Executed 3 platform
investments ranging from $100-$500M
EV, including YPrime, a clinical trial
technology provider, Canadian Hospital
Specialties, a medical products
manufacturer & distributor, and MGA
Homecare, a pediatric home healthcare
provider. Led team of 11 to execute 7
add-on acquisitions as Director of M&A
for Canadian Hospital Specialties.
Credit Suisse, New York, NY
Investment Banking Analyst, 2016-2018
Performed financial modeling and
valuation analyses to evaluate the
effects of various business transactions
including leveraged buyouts, mergers
and acquisitions and public offerings.
Advised on 3 M&A transactions with
aggregate enterprise value of ~$5B.
Elena D. Butler
Harvard College, Cambridge, MA
A.B., Magna Cum Laude, Applied Mathematics
with Organismic and Evolutionary Biology, 2010
University of Malaysia, Sabah
Fulbright Scholar, 2011, Perelman School of
Medicine at the University of Pennsylvania,
Philadelphia, PA, M.D. Candidate, 2024
An opportunity to use my clinical training,
strategic problem-solving skills, and
population health experience to improve
healthcare for underserved populations.
Pear VC
Venture Fellow, 2022-2024
Lead initial conversations with healthcare
founders. Conduct diligence for potential
investments.
IMPaCT / Penn Center for Community
Health Workers, Philadelphia, PA
Strategic Projects Associate, 2019-2022
Wrote articles with founder Dr. Shreya
Kangovi about Community Health Worker
(CHW) best practices and social determinants
of health for the Harvard Business Review
and the New England Journal of Medicine
– Catalyst. Created blueprint for a
national, technology-enabled CHW
program. With design consultant, built
wireframe and preliminary UX for social
needs screening mobile application.
Boston Medical Center Health System,
Boston, MA
Strategy Advisor to the Chief Medical Officer,
2017-2018
Developed ROI analyses, staffing model
and hiring plan for complex care
management programs serving top 3%
most complex patients across 4 ACOs
(~$10M budget). Created Behavioral
Health Community Partner strategy.
Managed daily progress dashboard during
health plan data exchange, ensuring
continuity of healthcare services for
110,000 members.
10
Sahil Chaudhary
Georgetown University, Washington, DC
B.S., Magna Cum Laude, Healthcare
Management & Policy, Georgetown University
An opportunity to leverage policy and
business to develop novel therapeutics
that improve access and care quality
Pfizer, New York, NY
Senior Summer Associate, Summer 2023
Developed secondary market access
insights on key changes in the oncology
ecosystem to grow and fortify a
multi-billion oncology portfolio
U.S. Senate Caucus on International
Narcotics Control, Washington, DC
Legislative Assistant (Policy Advisor),
2020-2022
Managed the Senate passage of 2
bipartisan resolutions, contributed to
a report on narcotic illicit finance
techniques & helped organize 5
drug control policy hearings
Office of U.S. Representative Eliot
Engel, Washington, DC
Senior Health Policy Advisor, 2019-2020
Led the enactment of 3 health laws
affecting public health, pharmaceutical
innovation and medical care. Created
and executed political & policy strategies
to secure billions for community health
care providers.
Office of U.S. Representative Diana
DeGette, Washington, DC
Health Policy Aide, 2017-2019
Co-managed the enactment of 4 health
laws affecting maternal health, tobacco
cessation, pharmaceutical innovation
and medical innovation.
Letícia Rubinstein
Cavalcanti
Politecnico di Torino, Italy
M.S., Automotive Engineering, 2018
Escola Politecnica da Universidade
de São Paulo, Brazil
B.S., Mechanical Engineering, 2018
An opportunity to foster healthcare
innovations development, especially
focused on biotech and medtech, to
improve people´s lives worldwide.
Morgan Stanley, San Francisco, CA
Summer Associate, Summer 2023
(Awarded the MBA Fellowship for high
performance)
Served industry-leading clients in Biotech
and Digital Health, including advising on
strategic sell-side M&A, target mapping
for top-tier pharmaceutical companies,
and pre-IPO positioning for immunology
and rare diseases biotech clients.
Grupo Oncoclínicas (McKinsey
Secondment Program), São Paulo, Brazil
M&A Specialist, 2021-2022
Grupo Oncoclínicas is the largest
oncology-care provider in LatAm and
has been under the Goldman Sachs MBD
management portfolio since 2016,
launching its IPO (~$689M) in 2021. I had
the opportunity to close 8+ M&A deals
to integrate a chain of end-to-end
oncological patient assistance nationwide
and spearheaded the new group’s
precision medicine division.
McKinsey & Company, São Paulo, Brazil
Business Analyst, 2019-2021
Worked on 10 industry-diversified
engagements, such as leading a team
to transform an ICU ventilator factory
to ramp up production by 26x in 4
months to supply the Brazilian emergency
COVID-19 ICUs’ demand — a partnership
work with the Brazilian Federal
Government.
Daphne W. Cheung
University of Pennsylvania, Philadelphia, PA
B.S.E., Summa Cum Laude, Bioengineering, 2019
M.S.E., Bioengineering, 2019
An opportunity to expand access to
life-changing therapies for patients
through innovation and business model
optimization.
Regeneron Pharmaceuticals,
Tarrytown, NY
Graduate Intern – New Products,
Summer 2023
Spearheaded end-to-end execution
of qualitative study with 7 KOLs for
late-stage drug candidate in rare
hematology disease area; synthesized
implications to update near- and
long-term forecasts for CEO in annual
budget review. Prioritized 10 global
markets to plan for drug candidate’s
first international launch in rare neurology
disease area; presented prioritization
recommendation to Commercial
leadership to kick-off global expansion
workstream.
Boston Consulting Group,
San Francisco, CA
Consultant, 2021-2022
Associate, 2019-2021
Core member of Healthcare and
MedTech practices. Stood up and
facilitated day-to-day execution of
Agile program consisting of 150+
developers and supporting team
members to accelerate software
product delivery timeline by 1+ years.
Analyzed 500+ clinical trials to quantify
upside for $50MM data asset acquisition
in the oncology space. Ascertained
additional revenue opportunity if tiered
pricing strategy were implemented to
drive 30% greater uptake of respiratory
panels in public health systems in client’s
3 primary emerging markets.
11
Karyll A. Davis
University of Pennsylvania, Philadelphia, PA
B.S.E., Magna Cum Laude, Bioengineering, 2017
Master of Biotechnology, 2018
An opportunity to catalyze the
development and commercialization
of innovative therapeutics through
transformational partnerships,
collaborations, and transactions in
the biopharmaceutical industry.
J.P. Morgan, New York, NY
Summer Associate, Summer 2023
Analyzed mergers, acquisitions, and
leveraged buyouts (LBO) for strategic
and financial buyers. In particular, analyzed
precedent biotech reverse mergers for
Korro Bio in relation to their merger with
Frequency Therapeutics; pitched a
dual-track process to a private,
clinical-stage platform biotech for
~$300M IPO and M&A. Presented final
project on hypothetical sale of a public
life science tools & diagnostics company,
including LBO, DCF, comparables and
qualitative evaluations, and ranked #1.
Pyxis Oncology, Cambridge, MA
Senior Manager, Business & Corporate
Development, 2021-2022
Led search and evaluation for transaction
opportunities and executed due diligence
for buy- and sell-side transactions.
Developed scientific and commercial
justification for ~$230M in-licensing
deal, adding best-in-class anti-Siglec-15
mAb to company pipeline.
Putnam Associates, Boston, MA
Consultant, 2021
Senior Associate Consultant, 2020
Associate Consultant, 2018-2019
Advised biopharmaceutical clients on
several dimensions of commercial strategy,
including but not limited to new product
planning, market access and pricing,
established brand strategy, NPV modeling
and forecasting. Worked closely with
the VP of Corporate Strategy and New
Product Planning at a commercial-stage,
mid-cap, CNS-focused biopharma across
>5 engagements, generating >$1M in
revenue for Putnam.
Benjamin L. Davis
Brown University, Providence, RI
B.A., Urban Studies, 2018
An opportunity to advise leading and
growing life sciences companies to help
enable innovative and more cost-
effective therapeutics.
JP Morgan, New York, NY MBA
Investment Banking Summer Associate, 2023
Advised life sciences and healthcare
services companies on M&A and
financing decisions by performing due
diligence, valuation, and strategic
assessments, and developing management
presentations. Select experience includes
sell-side M&A advisory, activist defense,
equity private placement, and buy-side
advisory for an asset acquisition.
Acsel Health, New York, NY
Consultant, 2020-2022
Analyst, 2019-2020
Led strategy consulting projects for
biotech and pharmaceutical companies
centered on portfolio strategy, landscape
analyses, and opportunity assessments
for new drugs across various therapeutic
areas. Conducted ~400 interviews with
KOLs, physicians, payers, and patients
to determine technical requirements
for new therapeutics to drive future
prescribing and market access.
IQVIA, New York, NY
Associate, 2018-2019
Spearheaded competitive assessments,
market analyses, forecasting reports
and go-to-market strategies for early-stage
pipeline assets and blockbuster products
for 6 of the 20 largest global pharma
manufacturers and rising biotechs.
Aided senior leadership in the development
of a new US financial institution consulting
practice, offering services to private
equity, hedge funds, and investment
banks in the healthcare sector by
identifying target clients, developing
thought leadership, and creating
templates for future analyses.
Brian D. Cortese
Northeastern University, Boston, MA
B.S., Summa Cum Laude, Biochemistry, 2019
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2024
An opportunity to wed my clinical skills
with my business acumen to advocate
on behalf of patients and providers.
Boston Consulting Group, Philadelphia, PA
Summer Consultant, Summer 2023
Served multinational pharmaceutical
client in revamping operations for 300+
brick-and-mortar sites to improve
operational efficiencies and unlock
>$100M in value. Identified in-person
operational challenges; tested, prioritized,
and scaled key solution elements; and
conducted big data analytics to generate
data-driven insights when measuring
effectiveness of hypothesized solution
elements.
Vanderbilt University Medical Center,
Nashville, TN
Medical Student Researcher —
Health Policy, 2022-2023
Led a series of health policy-related
projects and synthesized findings into
several first-author peer-reviewed
publications. Designed and analyzed
projects examining potential impact
of the Mark Cuban Cost Plus Drug
Company on Medicare Part D. Explored
impact of Medicare Part D provisions
within the Inflation Reduction Act
on patient out-of-pocket costs for
advanced prostate cancer treatment.
University of Pennsylvania Health
System, Philadelphia, PA
Medical Student Researcher —
Clinical Outcomes, 2021-2023
Designed several cross-sectional analyses
on the National Health Interview Survey
examining the impact of patient-level
demographic and clinical factors on
telemedicine utilization during the
COVID-19 pandemic. Conducted
retrospective cohort studies focusing
on the clinical manifestations and
genetic predictors of hereditary
urologic disease.
12
Seth I. Feldstein
seth.feldstein@[email protected]
Indiana University, Bloomington, IN
B.S. Business, Finance, 2018
An opportunity to develop and scale
unique care delivery models across
sites of care and services.
Aware Recovery Care, Philadelphia, PA
Strategic Operations Summer Associate,
Summer 2023
Developed the unit economics model
for Aware’s in-home addiction treatment
plan to facilitate internal operations
planning and payer negotiations.
Designed the 2025 go-to-market strategy
for beginning to serve Medicaid clients
in four states, inclusive of market entry
requirements and potential paths to
partnership in each state, increasing
total client census by 25%.
Humana, Louisville, KY
Senior Analyst, Corporate Development,
2020-2022
Modeled and managed the acquisition
of primary care practices, a post-acute
home health network and utilization
management company, and provider
network organizations. Led follow-on
investments in an in-home primary
care venture and an electronic claims
clearinghouse. Raised capital from leading
investment funds and structured the
initial partnership agreements in the de
novo behavioral health enterprise later
known as Author Health.
Waller Helms Advisors, Chicago, IL
Investment Banking Analyst, 2018-2020
Advised health care services and insurance
companies on M&A transactions and
minority investments. Prepared financial
models, managed due diligence and
quality of earnings processes, and
created management presentations to
complete $1B in total transaction value.
Rachel B. Feller
Tufts University, Medford, MA
B.S., Summa Cum Laude, Phi Beta Kappa,
Economics & Psychology, 2018
An opportunity to apply my passions
at the intersection of food, nutrition,
agriculture and sustainability towards
advancing human health outcomes.
Acre Venture Partners, Santa Monica, CA
MBA Investment Intern, Summer 2023
Supported investments in early-stage
companies addressing human and
environmental health through food &
agriculture solutions, evaluating financial
and strategic factors as well as
sustainability impact metrics. Developed
investment thesis on impact of Generative
AI technology on food & agriculture.
Tomorrow Farms, New York, NY
Manager of Strategy & Operations,
Winter-Spring 2022
Joined early-stage “future of food”
startup ($8.5M seed funding) as the 1st
non-executive employee, facilitating
strategic initiatives across operations,
creative, and growth teams to
commercialize a first-to-market animal-
free dairy milk beverage. Drove business
development for future products,
evaluating partnerships with
manufacturing and food science
companies while leading consumer
research.
Deloitte Consulting, New York, NY
Consultant, 2020-2022
Business Analyst, 2018-2020
Conducted 13 projects focused on
growth strategy, customer strategy
and innovation for clients spanning
pharmaceutical, provider, digital health,
and specialty pharmacy organizations.
Contributed towards the firm’s “Future
of Health” platform, equipping clients
to understand the impact of technological
and consumer shifts in the healthcare
industry on business strategy.
Wyatt. J Frasier
United States Military Academy, West Point, NY
B.S., Summa Cum Laude, Economics, 2017
An opportunity to lead revenue and
sales operations for a growing company
with a tenacious focus on revenue
growth and customer satisfaction.
Hona (YC W23), American Fork, UT
Sales Strategy & Operations, Summer 2023
Built a dynamic financial model to predict
burn rate and runway and used this to
help create and deploy hiring plan and
product pricing strategy for SMB and
middle market sales divisions as well
as series A raise strategy. Sourced and
acquired beachhead physical therapy
clients and implemented physical therapy
prospecting plan across the sales team.
Swinergy, Minneapolis, MN
Cofounder & COO, 2022-2023
Founded business to deploy novel tech
to convert pig manure more efficiently
to renewable natural gas for Midwest
farms. Secured purchase agreements
from Minnesota utility. Raised $700K
from 13 renewable-energy-focused
family offices and angel investors and
won the UPenn New Venture Challenge
($75K prize).
U.S. Army Officer, Anchorage,
AK & St Louis, MO
Medical Recruiting Team Leader, 2021-2022
Airborne Medical Platoon Leader, 2017-2021
Led medical recruiting team that interfaced
with 16 universities, 4 residencies, and
62 medical and dental practices: guided
team to 150% increase in medical
school recruitment for FY21 (12 to 30).
Led a 40-paratrooper medical team to
support a 500-person infantry battalion.
13
Helen Gao
Princeton University, Princeton, NJ
A.B., Magna Cum Laude, Economics, 2017
An opportunity to operate and grow
high-impact companies promoting access
and equity in healthcare.
Foodsmart, San Francisco, CA
Marketing Manager Intern, Summer 2023
Updated product offering for channel partners
representing 400+ employer clients by
streamlining pricing structure, introducing
tiered packages and optimizing incentives
to drive sales and telehealth visits.
Developed comprehensive outreach playbook
to engage in-network employers.
Conducted in-depth research on state
Medicaid benefit design to inform sales
team strategy and priorities.
Primus Capital, Atlanta, GA
Associate, 2020-2022
Completed 4 platform investments and 1
add-on acquisition, deploying $250M+ of
equity capital. Platform investments
include Lightbeam, a population health
management platform, CORL, a healthcare
vendor risk management solution,
PurpleLab, a real-world data platform
and Ambition, a sales coaching software.
Advised 7 portfolio companies and supported
value creation initiatives including evaluation
of add-on M&A opportunities, sales strategy
prioritization and launch of new pricing
model.
EY-Parthenon, New York, NY
Consultant, 2020
Senior Associate, 2019-2020
Associate, 2017-2019
Completed 19 growth strategy and commercial
due diligence projects in 5 industries.
Projects included evaluation of adjacent
growth markets for $1B+ revenue medical
transportation provider, M&A roll-up strategy
for national acute care provider and customer
segmentation for clothing subscription
company.
Disha Garg
Southern Methodist University, Dallas, TX
B.S., Mathematics with Applied Mathematics
Specialization, B.A., Economics, B.B.A.,
Finance, 2018
An opportunity to partner with and
build leading healthcare companies.
Element3 Health, Chicago, IL
Strategy and Operations Intern,
Summer 2023
Collaborated directly with COO to construct
and execute project plan for restructuring
consumer experience, perform market
analysis of key players, create product
and technical roadmap and build operating
models for external partnerships.
Cressey & Company, Chicago, IL
Private Equity Associate, 2020-2022
Evaluated and executed investment
opportunities across multiple healthcare
sub-sectors. Led portfolio monitoring
and supported value creation initiatives
— such as executing add-on M&A,
facilitating access to equity financing
and assisting with human capital
initiatives — for 4 portfolio companies
across the social determinants of health
and animal health sectors. Developed
whitepapers and led sourcing initiatives
across the hospice, home health, pet
insurance, medication management,
and healthcare technology sectors.
William Blair, Chicago, IL
Healthcare Investment Banking Analyst,
2018-2020
Advised healthcare services and
technology companies and financial
sponsors on M&A and financing
transactions.
Lilly Guo
University of Chicago, Chicago, IL
B.A., Economics, M.S., Computer Science, 2019
An opportunity to build innovative
healthcare technology products that
improve patient lives.
Duolingo, New York, NY
Product Manager Intern, Summer 2023
Ideated, designed and built prototype for
new choose-your-own-adventure
language learning feature powered by
GPT-4 to improve engagement of
long-form reading comprehension
sessions. Analyzed A/B experiments
for new and resurrected user onboarding
features and recommended future
feature iterations.
Oshi Health, Remote
Strategy & Operations Intern, 2022-2023
Analyzed patient reported outcomes and
chart review data of ~350 pilot patients
to determine clinical effectiveness of
Oshi’s novel telehealth care model.
Drafted abstracts and posters on Oshi’s
clinical impact for 2 medical conferences
alongside the Chief Medical Officer, Head
of Strategy, external R&D partner, and IBS
and IBD key opinion leaders.
The Boston Consulting Group, Chicago, IL
Consultant, 2021-2022
Associate, 2019-2021
Structured and analyzed SQL-based
claims databases covering 100M+
patients to identify market share and
referral volume opportunities for a
national physical therapy clinic operator.
Analyzed claims data for 2M+ multiple
comorbidity members and reviewed
medical literature across 7 disease areas
to design clinical care models for a
national health payer. Designed and
tested 6 patient growth pilots in response
to COVID-19 for a value-based primary
care provider.
14
Roni Hacham
Tel Aviv University, Tel-Aviv, Israel
B.S., Biomedical Engineering, 2020
B.S., Summa Cum Laude, Biology,
Neuroscience, 2020
An opportunity to combine my technical
and science skills with my healthcare and
business knowledge to solve persistent
healthcare problems.
Healthmap Solutions, Tampa, FL
Product Management Intern, Summer 2023
I crafted a data-driven risk stratification
model roadmap strategy aimed at enhancing
resource allocation efficiency, collaborated
with a diverse cross-functional team to integrate
technical, data-science, and business viewpoints,
and delivered a presentation of findings and
recommendations to the ELT.
Tel Aviv Medical Center, Tel-Aviv, Israel
Biomedical Engineer, Resident Neuroscientist,
2019-2022
Analyzed national neuroimaging data for
detection of neural disorders, improving
physicians’ choices regarding treatments.
Developed a machine learning model for
Parkinson’s disease diagnosis, now serving as
a baseline for research in Israel. Worked with
diverse teams worldwide to discover a novel
biomarker for early Parkinson’s disease
identification. Initiated study on early
Parkinson’s detection using fNIRS measures,
uncovering a new cognitive indicator for
the disease.
Israel Defense Forces, Israel
Sergeant, 2013-2015
My Unit specialized in developing advanced
systems, from development to implementation.
I was responsible for multi-million-dollar
projects – directing and collaborating with
high-ranked officers with diverse professional
backgrounds. I learned how to embrace
opinions, establish my authority, and navigate
and resolve conflicts in high-pressured
frameworks.
Christian W. Hanson
Brown University, Providence, RI
B.A., Economics, 2017
An opportunity to lead and grow a
mission-driven healthcare services
business that transforms patients’ lives.
Oshi Health, New York, NY
Strategy and Operations Intern,
Summer 2023
Designed long-term forecasting model
to project patient enrollment and clinician
hiring. Implemented a process to track
clinician utilization for Chief Medical
Officer. Built model to forecast profitability
based on patient enrollment and clinician
utilization trends for CFO. Wrote memo
on strategies for internal scalability
distributed to the CEO and leadership
team. Received offer to continue
consulting for team post-summer.
Bridgewater Associates, Westport, CT
Senior Finance Associate, 2021-2022
Finance Associate, 2018-2020
Managed 3 person finance team in
production of monthly income statement
and balance sheet for the CFO. Developed
$375M restructuring plan as part of
COO’s business strategy team; wrote
quarterly memos to Board of Directors
synthesizing progress against
implementation of restructuring plan.
Drove 5% cost reductions across 2021
as finance manager for Corporate and
Board departments.
General Electric, Chicago, IL
Financial Management Program, 2017-2018
GE Ventures rotation: Built cash-flow
model for two internal incubations;
projections used in investor pitch for
$1M Seed and $40M Series B funding,
respectively. GE Transportation rotation:
Tracked income, cash flow, and balance
sheet across $1B locomotive business.
Brendan T. Heiden,
M.D., M.P.H.S.
University of Notre Dame, Notre Dame, IN
B.S., Summa Cum Laude, Biochemistry 2014
University of Michigan, Ann Arbor, MI
M.D., Dean’s List, 2018; Washington University,
St. Louis, MO, M.P.H.S., 2021
An opportunity to leverage my
expertise in early-stage lung cancer
management and quantitative clinical
outcomes research to drive patient-
centered advances in the molecular
diagnostic and biopharmaceutical
industries.
Eli Lilly and Company, Indianapolis, IN
Intern, Accelerated R&D Leadership
Program, Summer 2023
Led a company-wide initiative through
the oncology medical affairs organization
related to medical insight generation
and artificial intelligence. Delivered final
recommendations to large audience
of senior executives across multiple
business units.
Washington University School of
Medicine, St. Louis, MO
Resident and Cardiothoracic Surgery
Research Fellow, 2018-present
General surgery resident at top-5 training
program. Experiences across adult and
pediatric, emergency and elective settings.
Co-led a national lung cancer research
team using real-world evidence
through the Department of Veterans
Affairs. Authored >40 peer-reviewed
publications in prominent medical
journals. Received early-career training
awards from the American Society of
Clinical Oncology and the American
Association for Cancer Research.
Oncocyte Corporation, Irvine, CA
Interim head medical officer & consultant,
2022-2023
Nasdaq-listed, oncology-focused,
precision diagnostic company. Assisted
with various roles across medical affairs,
medical education, and market access.
15
Lauren L. Hochman
University of Pennsylvania, Philadelphia, PA
B.A., Cum Laude, Biochemistry, 2017
An opportunity to develop and deliver
breakthroughs that transform
patients’ lives.
Thermo Fisher Scientific, Waltham, MA
Corporate Strategy Summer Associate,
Summer 2023
Supported key C-suite initiatives across the
$44B business. Projects included developing
presentation on potential of generative AI at
the company, two diligences of targets for
potential acquisition, and a board of directors’
update on the contract manufacturing and
pharmaceutical services business group.
The Boston Consulting Group, New York, NY
Consultant, 2021-2022 Associate, 2019-2021
Dedicated to BCG’s healthcare practice.
Supported the supply chain and manufacturing
and R&D divisions of Fortune 100
pharmaceutical clients. Expedited turnaround
time of novel CAR-T cell therapy product by
18%. Crafted strategy to manage distribution of
>500M doses of a medical countermeasure
on behalf of the U.S. Federal Government.
Received BCG’s Key to Purpose award for
Driving Inspired Impact.
The Children’s Hospital of Philadelphia,
Philadelphia, PA
Research Coordinator, 2017-2019
Co-authored 13 peer-reviewed publications
using national claims datasets containing
records of up to 80M patients to study
healthcare quality and outcomes. Analyzed
patient outcomes of the iCOMPARE trial,
published in the New England Journal of
Medicine and awarded “Publication of the
Year” in 2020 by AcademyHealth.
Nathan Hsu
University of Texas at Austin; Austin, TX
B.S., Mathematics, B.B.A., Finance, Business
Honors, 2018
An opportunity to operate and scale
digital health companies focused on
improving care delivery and patient
experience.
Element3 Health, New York City, NY
Strategy & Operations MBA Intern,
Summer 2023
Reported to CEO and advised on strategic
priorities including defining company
value proposition, branding, and mission.
Crafted proposal for new business line
to achieve 4x ROI, unlocking $1M+ in
incremental annual revenue opportunity.
Developed member personas and market
segmentation frameworks to establish
direct-to-consumer product offering
focus and identify target customer base
of 40,000+ eligible members.
Deloitte Consulting LLP; Dallas, TX
Business Analyst, 2018-2020
Consultant, 2020-2022
Managed day-to-day operations of
Product Innovation team, developing
asset use cases and cost savings estimates
to drive product adoption and generate
$1.8M in revenue for asset teams.
Collaborated with engineering, design,
and product teams to prioritize
commercialization features and
enhance user experience of employer
clinic service and patient scheduling
tools. Analyzed pricing data using
Tableau, SQL, and financial modeling
to benchmark 12,000+ services against
10+ client competitors, identifying
opportunities to achieve $20M+ in net
revenue growth. Developed a 5-year
roadmap prioritizing initiatives across
10 capability areas to drive a value-based
care transformation for a $4B organization.
Sanchit Jain
Columbia University, New York, NY
B.A., Summa Cum Laude, Economics, Middle
Eastern, South Asian, and African Studies, 2018
An opportunity to build and operate
products that extend access to healthcare
and drive improved health-seeking
behavior among underserved populations.
Elion, New York, NY
MBA Intern, Summer 2023
Assessed revenue potential for 10
technology categories and reviewed
product offerings of 200+ digital health
vendors to draft expansion strategy.
Conducted in-depth interviews with
technology buyers and vendors to build
product and marketing content for
customer relationship management
(CRM) category, helping 300+ business
users gain deeper insight about ~25
CRM products. Collaborated with
cross-functional team to build and
operationalize reviews product, defining
product specifications and managing
end-to-end hiring process for two new
operations hires.
Dalberg Advisors, Mumbai, India
Senior Consultant / Consultant, 2020-2022
Associate Consultant / Analyst 2018-2020
Assessed business models, addressable
market size, and impact potential of 8
healthcare opportunities in 10 emerging
economies to frame investment strategy
for sovereign wealth fund. Collaborated
with cross-functional team of global
non-profit to prototype and launch
health promotion programs, increasing
contraceptive use by ~16% and child
nutrition by ~15%. Led user research
and quantitative data analysis to identify
segments and design omnichannel
marketing promoting COVID-19 vaccines
among ~32M unvaccinated adults.
16
Saiesh Kalva
Rice University, Houston, TX
B.A. Biochemistry & Cell Biology, 2019
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2024
An opportunity to utilize digital health
and innovation to improve access to and
quality of surgical care.
Hospital of the University of
Pennsylvania, Philadelphia, PA
Sub-Internship, Summer 2023
Functioned as a resident physician on
two services: colorectal and breast
surgery. Independently rounded with
fellows and attendings on complex
surgical patients, formulated treatment
plans, and assisted in surgical operations.
Lucile Packard Children’s Hospital
Stanford, Palo Alto, CA
Sub-Internship, Summer 2023
Functioned as a resident physician on
the pediatric surgery service. Routinely
worked with physician assistants and
residents to manage inpatient needs
including triaging consults and working
with ancillary teams. Assisted in surgical
operations.
UCLA Mattel Children’s Hospital,
Los Angeles, CA
Sub-Internship, Summer 2023
Functioned as a resident physician on
the pediatric surgery service. Managed
inpatient needs and assisted in surgical
operations. Independently saw and
determined the course of care for
patients in clinic.
Penn Medicine Center for Healthcare
Innovation, Philadelphia, PA
Medical Student and Innovation Fellow,
2020-Present
Developed a digitally enabled home-
based strategy for 1900+ breast
patients to safely coordinate pre-
and post-operative care. Working
to develop protocols to monitor
post-operative cardiac patients.
Colin P. Kenney
Vanderbilt University, Nashville, TN
B.S., Human & Organizational Development,
Health and Human Services, 2018
An opportunity to invest in, partner
with, and scale healthcare services
companies.
Nyx Partners, New York, NY
Chief of Staff to Co-CEOs, Summer 2023
Evaluated new acquisition targets and
assisted with diligence of existing M&A
opportunities. Developed and
implemented recommendations
for operations improvements and
cost-savings initiatives. Created value
creation playbook for integration of
future acquisitions.
Linden Capital Partners, Chicago, IL
Associate, 2020-2022
Evaluated investment opportunities
and managed portfolio companies
across multiple healthcare sub-sectors
for one of the country’s largest healthcare
-specific private equity funds. Led platform
investment in the world’s largest medical
device regulatory and compliance
consulting company. Led merger of a
pain management-focused clinical trial
company with a contract research
organization. Assisted fund President
and Head of IR with $3B fundraising
effort.
Bank of America, New York, NY
Analyst, 2019-2020
Member of the Global Healthcare
Group. Advised companies on M&A
transactions and equity and debt
financings. Two closed IPOs and one
closed M&A transaction of public biotech
company to European sponsor.
Geoffrey S. Lee
University of Pennsylvania, Philadelphia, PA
M.S.E., Biomedical Engineering (Computational
Neuroscience), 2012; B.S.E., Cum Laude,
Economics, Finance | Biomedical Engineering, 2011
An opportunity to invest in and operate
healthcare businesses to improve the lives
of patients.
Goldman Sachs, New York, NY
Associate, Summer 2023
Developed financial models, valuations, and
information memos, aiding in the $1.4B sale
of a leading Hospitality Chain to a Private
Equity sponsor. Managed a $9B activism and
defense strategy. Developed credit models
and negotiated a $1B+ credit facility refinancing.
LB Private Equity, Seoul, South Korea
Investment Associate, 2022
Evaluated growth equity, buyout, and carve-out
opportunities. Led new investments, financial
valuation, due diligence, and portfolio
management. Selected transactions: $300M
Consumer Health carve-out and $800M Info
Tech buyout. Selected portfolio management
in Industrials and Fintech.
Oliver Wyman, New York, NY
Associate Partner, 2017-2022
Established and grew the Healthcare Private
Equity platform in Asia, specializing in provider,
health-tech/IT, and payer assets. led 50+
major provider transactions during tenure.
Selected for a fully funded transfer to
New York.
Kearney, New York, NY
Engagement Manager, 2012-2017
Specialized in Healthcare, Tech, and Consumer
sectors, leading strategy, operations, and
commercial diligence projects. Progressed
from Business Analyst to Engagement
Manager and was selected for a fully funded
exchange to Singapore.
17
Daniel P. Letscher
Northwestern University, Evanston, IL
B.A., Computer Science, 2017
An opportunity to leverage expertise in
software development and delivery to
create products that enable a robust
digital health ecosystem.
Amazon, Bellevue, WA
Senior Product Manager – Technical Intern,
Summer 2023
Designed new product architected with
generative AI technology launching to
Amazon end-users at scale. Drove
alignment among stakeholders across
Artificial General Intelligence organization
for product vision. Outlined three-year
strategy for product suite powered by
shared generative AI technology.
Tebra, Santa Monica, CA
Senior Software Engineer, 2021-2022
Software Engineer II, 2019-2021
Drove delivery as senior engineer on
three teams, developing a software-as-
a-service product suite for private
medical practices. Led integration of
overseas technology platform pre-
and post-acquisition of the vendor.
Established organizational coding stan-
dards and mentored junior engineers.
Oracle, Redwood Shores, CA
Software Engineer, 2019
Associate Software Engineer, 2017-2019
Developed next-generation software
development kit to power partner-
developed cloud applications. Led
team as Scrum Master in product
design and refinement, achieving
buy-in across a variety of stakeholders.
Cesar D. Lopez, M.D.
Stanford University, Stanford, CA
B.S., Biology; Minor, Economics, 2016
Columbia University, New York, NY
M.D., 2021
An opportunity to make a meaningful
impact on the management and develop-
ment of innovative products for a medical
device or healthcare technology company.
McKinsey & Company, New York, NY
Summer Associate, Summer 2023
Worked with real estate developer to build
investment pitch to finance newly formed
operating/management company and
property company with portfolio of next-
generation office properties. Collaborated
with client’s senior management team to
create post-raise strategy to develop and
manage new office concept. Built real
estate models forecasting cash flows and
investment returns for proposed operating
and property company entities.
Butterfly Network, New York, NY
Pre-MBA Intern, Client Experience
Operations & Strategy, Summer 2022
Developed post-sale strategy to improve
KPI tracking and increase user engagement
and adoption of handheld ultrasound
devices and AI cloud platform for medical
education client portfolio with ACV of
over $125M. Collaborated with senior
management of various teams to identify
operational issues in medical education
client experience, implement improve-
ments, and generate proposals with
high-growth potential to business
development team. Built capacity
planning model for volume and staffing
of client support team handling thousands
of daily touchpoints.
NewYork-Presbyterian Hospital, Columbia
University Medical Center, New York, NY
Resident Physician, Orthopedic & General
Surgery, 2021-2022
Assisted orthopedic, general, and plastic
surgeons in performing over 100
procedures at a high-volume urban
medical center. Prepared and supervised
post-surgical treatment and recovery
plans for patients, managed surgical
complications and acute conditions.
Hope Lu
University of Pennsylvania, Philadelphia, PA
B.A., Biology, 2020; The Wharton School of the
University of Pennsylvania, Philadelphia, PA
B.S. in Economics, Summa Cum Laude, Finance, 2020
An opportunity to develop and
commercialize innovative therapies that
will reach patients and improve lives in
a meaningful way.
AstraZeneca, Wilmington, DE
MBA Intern, Summer 2023
Partnered with cross-functional
colleagues and external agencies to
develop and implement marketing
tactics for growing respiratory brand.
Assets targeted healthcare professionals
via multiple channels (e.g., social media,
branded websites, digital banners).
Evaluated attractiveness of consumer-
oriented external partnership with
NASCAR, culminating in final presentation
featuring conclusions on partnership
effectiveness in reaching target audience,
increasing brand awareness, aligning to
AZ’s sustainability goals, and high-level
financial ROI; research findings also
incorporated into external presentation
to partner prior to resigning contract.
Boston Consulting Group, Philadelphia, PA
Associate, 2020-2022
Strategy consultant for healthcare
(mainly biopharma, medtech) and public
sector organizations. Performed program
management for divestment of generic
division within a global pharmaceutical
company. Conducted investment
opportunity analysis for MedTech
player in oncology diagnostics and
developed strategic plan for provider
system to improve patient access to
digital tools via journey-mapping. On
behalf of government clients, executed
market analysis on Wearable technologies
and provided recommendations on
investment allocation across multiple
high impact projects / clinical studies
related to COVID.
18
Lucy Luo
National University of Singapore, Singapore
Bachelor of Business Administration, 2014
An opportunity to tackle complex treat-
ment, diagnosis and access challenges
for underserved patient communities.
Vertex Pharmaceuticals, Boston, MA
Marketing Science, Early Pipeline,
Summer 2023
Built commercial strategy to increase
diagnosis rate and presented to
Commercial Leadership Team and
cross-functional Disease Strategy Team.
Led insight projects for rare neurological
disease, including understanding patient
journey and archetypes, developing
provider mapping and executing TPP
testing. Created high-level forecasting
model for long-range planning.
Boston Consulting Group, Tokyo, Japan
Consultant, 2020-2022
Senior Associate, 2019-2020
Concentrated as healthcare consultant,
with projects spanning Biopharma
(70%), MedTech (20%) and Big Tech in
Health Care (10%) on corporate planning,
growth strategy, product marketing /
launch plan, M&A, and org. transformation.
Example projects include 5-year growth
strategy project for American rare disease
biopharma. China market entry for
Japanese biopharma. Due diligence and
commercial model design for acquisition
of U.S. biotech (US$3b). Global R&D
sequencing and launch strategy for cell
therapy targeting rare disease. GTM
strategy for Technology company’s
entry into health care.
Temasek International, Singapore
Associate, 2015-2018
Orchestrated cross-functional teams for
mid-range planning and analytics projects.
Westpac Banking, Singapore
Institutional Banking Analyst, 2014-2015
Led crafting of proposals and
establishment of credit facilities
for large institutional clients.
Evan J. Marks
Georgetown University, Washington D.C.
B.S., Cum Laude, Operations & Information
Management / Marketing, 2014
An opportunity to improve population
health through technology.
NeuroFlow, Philadelphia, PA
Product Strategy and Corporate
Development Associate, Summer 2023
Reported to CPO and advised C-suite on
long-term product and M&A strategy,
including development of cross-functional
strategic proposals, partnership and
acquisition target analysis, and investment
theses. Created three market segmentation
and landscape assessments that analyzed
strategic relevance of potential target
markets, clarified optimal M&A pathways
based on competitive analysis, and
prioritized ~15 targets for further diligence.
Vynamic, Philadelphia, PA
Manager 2, 2021
Manager 1, 2020
Led health tech and biopharma
consulting engagements, interfacing
directly with senior executives to guide
commercial strategy, product visioning
and competitive positioning. Led
commercial market assessments to
inform differentiating technology
investment opportunities, driving a $5M
investment for insights and patient
support technology solutions projected
to gross $30M annually.
ZS, Philadelphia, PA
Associate Consultant, 2018-2020
Associate, 2015-2017
Advised biopharma sales and marketing
leaders in strategic decision-making
through design, management and
execution of market research and data
analysis. Managed global teams in 20+
advisory engagements with 8 biopharma
firms.
CEB (now Gartner), Arlington, VA
Research Analyst (IT Practice), 2014-2015
Developed syndicated primary research
with C-suite IT executives at F500
corporations.
Moira C. McChesney
University of Pennsylvania, Philadelphia, PA
B.S., Summa Cum Laude, Nursing, 2015
An opportunity to better the health of
individual’s through improving health
care delivery and increasing access to
primary care.
DaVita, Denver, CO
Redwoods Associate, Summer 2023
Conducted interviews with stakeholders
across the organization, ranging from
patient care tech to vice president to
assess current state of collaboration
between value-based care teams and
in-clinic dialysis teams. Additionally,
created playbook identifying key barriers
and detailed solutions, including
implementation plan, to better integrate
value- based care teams within the
daily operations of dialysis clinics
Accenture, Philadelphia, PA
Clinical Innovation Consultant, 2021-2022
Senior Consulting Analyst, 2020-2021
Consulting Analyst, 2019-2020
Collaborated with payers, providers and
integrated delivery systems to identify
opportunities, including utilization
management and care management,
for medical cost savings and/or quality
improvement through analysis of various
data sets. Led workstream, managing
senior analysts in 6-week solution
design and 3-month implementation
of 5 initiatives with annualized opportunity
of $30M. Contributed to team’s overall
operations, by developing and
maintaining project dashboards and
action item trackers.
Independence Blue Cross, Philadelphia, PA
Medicare Advantage Co-Op, 2018-2019
Collaborated with business and software
team to create provider application
with goal of increasing risk capture and
improving STARs performance for at-risk
provider group.
19
Mitchell E. McCollum
Georgetown University, Washington, D.C.
B.S.B.A., Magna Cum Laude, Finance and Ac-
counting, 2015
An opportunity to invest in health care
companies that reduce the total cost of
care by improving patient outcomes.
Caregiver, Fort Worth, TX
Financial Analyst, Summer 2023
Developed reporting packages, which
established new key performance
indicators and helped regional managers
improve operational efficiency.
Collaborated with CEO to implement
new organizational structure and
promote better alignment between
clinical, behavioral and operations
functions. Assessed viability of several
growth opportunities, both within
Caregiver’s existing service offering and
opportunities for service line expansion.
WindRose Health Investors, New York, NY
Associate, 2019-2022
Evaluated investment opportunities
across the health care services industry,
including potential leveraged buyouts
and growth equity investments.
Executed four new platform investments
and two portfolio company exits.
Provided support to portfolio companies’
management teams by evaluating
potential add-on acquisitions, analyzing
alternatives, constructing budget and
forecast models, negotiating financing
documents and managing sale processes.
Leerink Partners, New York, NY
Analyst, 2017-2019
Advised 15 companies across the biotech,
medical device, diagnostics and health
care services sectors of health care on
mergers and acquisitions. Created
marketing materials, built financial
models and coordinated diligence on
behalf of clients in both buy-side and
sell-side transactions.
Thomas D. McGrath
Vanderbilt University, Nashville, TN
B.A., Cum Laude, History & Political Science, 2017
An opportunity to build businesses that
promote health and prevent disease.
Element3 Health, Remote
MBA Intern, Summer 2023
Developed the go-to-market strategy for
a provider of social fitness benefit programs
to Medicare Advantage plans. Spearheaded
the design and implementation of a
direct-to-consumer product growth
strategy. Created and maintained a KPI
dashboard to measure go-to-market
success.
Five Arrows Capital Partners,
New York, NY
Private Equity Associate, 2019-2022
Evaluated healthcare and technology
investment opportunities for the U.S.
private equity arm of Rothschild Merchant
Banking, a diversified investment firm
managing over $15 billion of assets.
Closed 2 platform investments, 8 add-on
acquisitions, and 3 debt financings.
Collaborated with executive teams to
drive corporate strategy and development.
Performed extensive research on subsectors
within healthcare and software, creating
sector deep dives that guided the firm’s
investment focus.
Houlihan Lokey, New York, NY
Investment Banking Analyst, 2017-2019
Advised clients across the industrials
sector and executed several sell-side and
buy-side M&A transactions, including the
sale of Trojan Battery Company to C&D
Technologies and the sale of Plateau
Excavation to Sterling Construction
(NasdaqGS: STRL). Led analyst recruiting
at Vanderbilt.
Nicholas R. Mehta
Western University, London, Canada
B.M.S.c., Western Scholar, Honors Specialization
Interdisciplinary Medical Sciences, 2018
Ivey Business School, London, Canada; B.A., Ivey
Scholar, Honors Business Administration, 2018
An opportunity to help drive strategic,
cross functional business initiatives to
improve the delivery of and access to
primary care.
Patina Health, Bala Cynwyd, PA
Strategic Operations, Summer 2023
Evaluated entry into Direct Contracting
Medicare market to double addressable
patient base via regulatory review,
financial analysis, and care model
assessment. Established new market
entry playbook following Charlotte
market launch. Prepared valuation
analysis as part of Series B fundraising.
Reviewed payer contracts to align care
delivery model. Led discussion with
senior leadership on all findings.
TPG Capital, London, United Kingdom
Associate, 2020-2022
Defined European healthcare landscape
for TPG, identifying a target focus in
generic pharmaceuticals following
interviews across 27+ different markets,
and developed thesis leading to
acquisition of DOC Generici, an Italian
generic pharma business, for ~€1.5BN.
Guided exit and wind-down of financial
structures for two portfolio companies.
Organized and drove weekly healthcare
meetings and thematic research in
pharma services sector.
Citigroup, London, United Kingdom
Investment Banking Analyst, 2018-2020
Worked across the EMEA region to support
clients with strategic and financial
advice in the pharmaceuticals, healthcare
services, medical technology, and
biotechnology sectors. Provided clients
with support in strategic reviews, M&A,
and equity & debt financing.
20
Mohammed A. Omer
Harvard Kennedy School, Cambridge, MA
MBA-MPA Dual Degree Candidate, Center for
Public Leadership Fellow, 2025
NYU Abu Dhabi, UAE
B.A., Economics and Social Research and Public
Policy, 2014
Seeking opportunities to invest in
and manage companies that deliver
sustainable returns and social impact,
including improved, equitable health
outcomes.
Ocean 6 Partners, Abu Dhabi, UAE
Consultant, ESG Framework Development,
Summer 2023
Advised Senior Management of
a UAE-based Healthcare network.
Developed an ESG framework as part
of planned IPO materials.
Abu Dhabi Investment Office, Abu
Dhabi, UAE
Healthcare and Biopharma Sector Lead,
2021-2022
Promoted innovation-forward polices,
represented ADIO internationally, and
mobilized Government to support
investors. Structured incentives from
a $14bn fund to attract 100+ investors,
deliver >$1.5bn in foreign direct
investment, and create 1,380+ jobs.
Mubadala Investment Company,
Abu Dhabi, UAE
Associate, 2020 – 2021
Senior Analyst, 2017
Analyst, 2014
Led projects in primary care expansion
for underserved communities and
healthcare reimbursement reform.
Delivered implementation plan
incentivizing health outcomes, while
reducing annual cost growth by 65%.
Led overhaul of Quality, Patient Safety
and Patient Experience Governance
framework. Chaired COVID-19
Occupational Health Committee to
preserve critical healthcare capacity,
and advise Government. Managed
scientific team in designing and 3D
printing PPE, extending supplies for
6 months. Mentored colleagues via
weekly structured teach-ins. Conducted
due diligence and operational integration
analysis on 2 $300m+ acquisitions.
Allison Z.L. Ng
University of Cambridge, U.K.
B.A., Chemistry, 2016
An opportunity to make healthcare accessible
to marginalized populations in every part
of the world.
Taiwan Mobile Ventures, Taiwan
Corporate Development, Summer 2023
Assisted Venture Capital team in sourcing,
evaluating and negotiating deals. Identified
new strategic investment opportunities
worth $100M.
Bain & Co. Consulting, Malaysia
Senior Associate Consultant, 2021-2022
Associate Consultant, 2021
Served in Bain’s Healthcare Practice, delivering
PE due diligence and strategy engagements.
Sourced partners for MedTech to launch
low-cost diabetes devices in developing
nations. Created growth strategies for unicorn
digital health player, pharmaceutical
distributor and cross-borders telehealth
company.
Kearney, Malaysia
Associate, 2021
Senior Business Analyst, 2019-2020
Business Analyst, 2018-2019
Led projects in Social Impact. Worked with
SME bank to increase reach of loans to rural
areas. Defined energy transition strategy for
Utility Co. to achieve net zero carbon
emissions. Evaluated use of 5G wireless
network to reach populations without
internet access.
IQVIA, Malaysia
Business Analyst, 2016-2018
Drove 5 market entry projects for Big
Pharma and Biotech, delivering analysis in
demand, competition, regulatory approval,
patient pathways and drug listing.
World Health Organization, Switzerland
Emergency Response Data Intern, 2016
Worked with cross-functional teams to
control spread of Ebola in Sierra Leone.
An opportunity to drive the creation and
delivery of transformative therapeutics
for patients by leveraging my combined
clinical and business training.
RTW Funds, New York, NY
Research Intern, Summer 2023
Performed investment diligence on
various therapeutic areas and modalities
across the lifecycle of biotechnology
companies via independent analysis,
KOL calls, and discussions with company
leadership. Evaluated in vitro and in
vivo efficacy, toxicology, and PK/PD
data alongside clinical endpoint-related
patient data. Presented views directly
to the broader investment team on
three occasions.
BigHat Biosciences, San Mateo California
Business Development Intern, 2022-2023
Developed pipeline strategy and
indication prioritization alongside Chief
Business Officer and Chief Executive
Officer. Assisted with capital raising
work ($80M Series B raise July 2022)
and pharma partnership efforts.
Coordinated with translational research
team to align asset development plan
with commercialization goals.
McKinsey & Company, Philadelphia, PA
MD Fellow, 2021-2022
Worked in project teams within healthcare
practice to deliver impact for clients
across public and private sectors while
on leave from medical school. Advised
one of the nation’s largest health systems
on COVID-19 response planning and
vaccination efforts. Served 6
biopharmaceutical clients on R&D
strategy, market entry, clinical trial
design, and regulatory approach.
Karan R. Naik
Ohio State University, Columbus, OH
B.S., Biomedical Science, Summa Cum Laude
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2024
21
Sonia P. Parekh
Columbia University, New York, NY
B.A. Economics 2017
An opportunity to catalyze transformative
advancements in life sciences through
strategic investments, fostering a future
defined by groundbreaking medical
solutions and improved global health.
Aditum Bio, San Francisco, CA
MBA Intern, Summer 2023
I worked at a life-sciences investment
fund, evaluating pre-clinical assets
within the autoimmune disease space.
I used scientific research and market
analysis to evaluate potential investments
and built detailed valuation models for
portfolio companies shaping investment
strategy and providing pivotal support
for a $2B sale.
Longitude Capital, Menlo Park, CA
Venture Capital Associate, 2019 - 2022
Worked for a healthcare venture capital
firm conducting due diligence to assess
potential investments across the
healthcare space. I developed robust
financial models, analyzing various
scenarios to gauge cash requirements
and valuation sensitivities, and distilled
the insights from operational, clinical,
and financial due diligence into
investment memoranda for the
Investment Committee’s consideration.
Credit Suisse, New York, NY
Healthcare Investment Banking Analyst,
2017-2019
Within the Healthcare Investment
Banking group, I created intricate models
for complex transactions, such as
patient-flow revenue projections and
simulation analyses involving different
financing and acquisition scenarios.
Additionally, I conducted competitive
landscape analyses across diverse
therapeutic areas, including women’s
health, oncology, and autoimmune
diseases, through benchmarking exercises
that compared pipeline assets, capital
structures, and financial performance.
Aniket Patel
University of Pittsburgh, Pittsburgh, PA
B.S.E., Bioengineering, magna cum laude, 2014
Tattvagyan Vidhyapeeth, Mumbai, India
Certificate, Comparative Eastern and Western
Philosophy, 2016; University of Pennsylvania,
Philadelphia, PA, M.S.E., Bioengineering, 2019
An opportunity to leverage my technical
and business skillset in the healthcare
finance industry.
MTS Health Partners, New York, NY
Investment Banking Summer Associate,
Summer 2023
Provided strategic advisory across 4 live
deals with an aggregate value of $2.5B+
in the life sciences and healthcare services
sectors. Built complex valuation models,
conducted sensitivity analyses, and
performing discounted cash flow analyses.
Deloitte Consulting, Philadelphia, PA
Consultant, 2020-2022
Analyst, 2019-2020
Directed strategy of NIH management
system overseeing 24 labs and startups
developing COVID-19 diagnostics.
Developed 18 pitch decks to help clients
secure $23M VC funding. Facilitated
migration of 20M+ members from old
to new Pharmacy Benefit Manager for
payor client.
Recupero Robotics, Philadelphia, PA
Technical and Business Development
Intern, Summer 2018
Directed technical development of
smart toy to quantify 6 biometrics for
early diagnosis of neurodevelopmental
delays. Coordinated development of
business case and commercialization
plan to secure $1.5M funding.
Eurofins Scientific, Lancaster, PA
Scientist-1, 2017
Associate Scientist, 2016-2017
Conducted standardized tests on drug
products and substances to ensure
compliance with FDA regulations.
Achieved 0.4% error rate, 1.4% below
average.
Andrew Parambath
University of Pennsylvania, Philadelphia, PA
B.A., Summa Cum Laude, Biology, 2017
M.Ed. Honors, Education, 2019
M.D./M.B.A. Candidate Perelman School of
Medicine and Wharton
An opportunity to combine my clinical
skills with business and investing
knowledge to innovate in healthcare
delivery.
ClearView HealthCare Partners,
New York, NY
Senior Consultant, Summer 2023
Executed 2 projects related to market
entry, launch planning, strategy and
diligence. Led a high-performing team
in executing Key Opinion Leader (KOL)
research, conducting a series of in-depth
interviews and calls to gain critical
insights into the competitive landscape,
which directly influenced the client’s
strategic decision-making process.
Pear VC, Menlo Park, CA
VC Fellow, 2022-Present
Served as a Venture Capital (VC) fellow
and actively engaged in sourcing and
conducting investment due diligence
for a seed-stage fund managing $400M
in assets under management (AUM)
Managed healthcare investments and
examined deals between $25K to $2M
for potential health companies
Teach For America, Dallas, Tx
Chemistry Teacher, 2017-2019
Taught chemistry to 120 students from
low-income backgrounds and served as
a coach for various clubs and sports
team. Designed new pedagogical
practices in classroom leading to high
performance on district exams
22
Jeffrey L. Roberson,
M.D.
University of Virginia, Charlottesville, VA
B.A., With Distinction, Global Public Health,
Spanish, 2014; The George Washington
University, Washington, DC, M.D., 2019
An opportunity to improve the education
and support of medical trainees to
ultimately impact care delivery.
The Hospital of the University of
Pennsylvania, Philadelphia, PA
Administrative Chief Resident,
Summer 2023
Coordinated all onboarding activities
and training for new residents within
the Department of Surgery. Responsible
for creating the academic schedule for
all trainees over eight training levels as
well as creating and executing an
educational curriculum.
The Hospital of the University of
Pennsylvania, Philadelphia, PA
Resident in General Surgery, 2019-Present
Training at a large, tertiary care hospital
for a career in academic general surgery
with a focus in colon and rectal surgery.
Engaged in research on the genetics of
benign diseases of the colon and
anorectum as well as surgical quality
improvement.
Jenee A. Rideaux
Vanderbilt University, Nashville, TN
B.A., Global Economic Development, 2015
An opportunity to scale digital health
companies that improve health disparities.
Oxeon Venture Studio, New York, NY
Summer Associate, Summer 2023
Led the first phase of a company
launch, including competitive analyses
and market sizing. Pressure tested
company ideas with industry experts.
Presented findings to the CEO. Initiated
a company-wide process to strengthen
relationships with potential customers
and identify health plan priorities.
Olive, New York, NY
Product Innovation Lead, 2022
Solutions Architect, 2021
Led customer success and account
expansion efforts for health system
contracts over $10M. Designed and
orchestrated the implementation of
RPA software that automated care
coordination, population health and
revenue cycle tasks.
Huron Consulting Group, New York, NY
Manager, 2019-2021
Associate, 2017-2019
Analyst, 2015-2017
Partnered with health system executives
to design and implement process
improvement solutions related to
population health, patient throughput
and reimbursement. Projects included:
Led a team of 5 to restructure the
capacity management program for an
800-bed hospital. Drove the remote
implementation of care coordination
and claims management programs
achieving $960,000 in increased
revenue. Managed team of 7 to assess
a health system’s clinical operations,
optimize staff workflows and design 5
patient experience programs, leading to
$15M in savings and revenue growth.
Hagen F. Puller
Harvard College, Cambridge, MA
A.B., Cum Laude, Molecular and Cellular Biology,
2018; Perelman School of Medicine at the
University of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2024
An opportunity to meaningfully
integrate medical expertise with drug
development experience and help bring
forth promising treatment options to
address patients’ unmet need.
General Atlantic, New York, NY
Life Sciences Fellow, Fall 2023
Prepared investment committee
presentation highlighting key implications
of the Inflation Reduction Act’s
Medicare Drug Price Negotiation clause
to development and commercialization
strategy for key portfolio company
assets; led research to evaluate a novel
therapeutic class in the management of
hypersomnolence disorders and utilized
findings to craft an investment thesis
that defined major risks, opportunities,
and related new deal sources.
ClearView HealthCare Partners,
New York, NY
Senior Consultant, Summer 2023
Conducted an opportunity assessment
for an oncology bispecific antibody
company to inform their expansion into
mechanistically adjacent therapeutic
areas, managing an independent
workstream of primary and secondary
research to map current treatment
paradigms and unmet need in a broad
set of indications; designed an
epidemiology-based forecast to project
future revenue generation for the
highest-margin product of a large
contract development and
manufacturing organization.
23
Nirav V. Sampat
Stevens Institute of Technology, Hoboken, NJ
M.E., Systems Engineering, 2018
B.E., High Honor, Mechanical Engineering, 2018
An opportunity to advise and empower
technology-driven healthcare companies
by facilitating transactions and fostering
growth.
Guggenheim Partners, New York, NY
Investment Banking Summer Associate,
Summer 2023
Advised healthcare services, medical
device, and biopharma companies on
various financial transactions. Led
valuation, due diligence, market
research, strategic assessments, and
development of management
presentations for sell-side M&A,
buy-side M&A, and licensing deals.
Deloitte Consulting, New York, NY
Consultant, 2020-2022
Analyst, 2018-2020
Advised health plan and HCIT clients on
various growth strategy and business
transformation engagements. Select
experiences include: 1) Developed
go-to-market and growth strategies for
$1B geographic expansion initiative for
large national health plan following
major changes in regulatory and
competitive landscape 2) Defined digital
transformation strategy for healthcare
IT services provider to increase speed to
market for new products 3) Drove ACA
Exchanges market entry initiative for
large national health plan 4) Led claims
adjudication process redesign for large
national health plan, enabling processing
of $90B of claims per year.
Thomas M. Ross
Georgia Tech, Atlanta, GA
B.S., Highest Honors, Industrial & Systems
Engineering, 2018
An opportunity to add the care into
health care.
route, Philadelphia, PA
Co-founder, Summer 2023
Built a self-guided therapy startup with
a clinician, former venture capitalist
and fellow Wharton MBA. Led product
efforts by conducting market research,
modernizing decades of clinical methods,
and coordinating MVP build. Developed
business plan and go-to-market strategy.
Recruited and managed 5 operators
and 4 advisors.
Deloitte, Atlanta, GA
Consultant, 2019-2022
Strategy and operations consulting with
a focus on novel health care partnerships,
operations transformations, and financial
modelling. Built predictive analytics for
the health care provider practice. Led
stepupGA: Deloitte’s pro-bono consulting
chapter in Atlanta.
Teach For America, Miami, FL
Mathematics Teacher, 2018-2019
Taught 102 students and increased the
share who passed the state math exam
from 20% to 31%, allowing them to
enroll in the college-track algebra
course in 8th grade.
Margaret L. Rollins
Dartmouth College, Hanover, NH
B.A., Cum Laude, History, 2015
An opportunity to build and scale
value-based healthcare delivery models
and technology that address health and
social needs for vulnerable populations.
Author Health, Boston, MA
Strategy & Operations Intern, Summer 2023
Developed and operationalized a
multi-modal enrollment strategy to
engage Medicare Advantage members
with serious mental illness in an
innovative value-based behavioral
health program. Led team of
Community Health Workers to engage
in field-based outreach to hard-to-reach
and high-need individuals across South
Florida.
Eleanor Health, Boston, MA &
New York, NY
Senior Manager, Growth Operations,
2021-2022
Interim Director of Operations, Ohio, 2021
Various Market Implementation & Growth
Operations Roles, 2019-2021
Led Growth Operations function and
team responsible for new market
launches, real estate, operations excellence,
operations analytics and special projects.
Launched Eleanor in 4 new markets
and implemented 5 value-based
population health contracts with large
national payers and Medicaid MCOs.
Oxeon Partners, New York, NY
Senior Associate, 2017-2019
Associate, 2015-2017
Partnered with C-Suite and Board of
early-stage and high-growth healthcare
companies to develop and execute on
talent strategy. Managed 40+ C-level
and SVP-level executive searches, owning
day-to-day project execution, team
strategy, client management, candidate
management and offer negotiations.
24
An opportunity to accelerate
pharmaceutical innovation by
building meaningful pharma-biotech
partnerships
BioNTech, Cambridge, MA
Corporate Development and Strategy
Intern, Summer 2017
Valued a CGT biotech through two
independent methodologies (incl. DCF)
to inform executive board’s deal
negotiation. Analyzed internal business
case for commercial and manufacturing
strategy of a CAR-T therapy program.
Presented results to exec board and
supported further C-level decision
making with various other research
and analytics.
The Boston Consulting Group,
Zurich, Switzerland
Consultant, 2020-2022
Associate, 2018-2020
Core member of Healthcare and Private
Equity practices. Assessed commercial
due diligence of health care firms to
inform M&A decisions (targets ranging
from $15M to $1B+ revenues). Defined
pharmaceutical market access and
launch strategies using value based
healthcare. Led workshops and supported
PMO for 3 major global organizational
transformations of Biopharma &
MedTech clients. Elected to represent
70 peers as Cohort Leader.
IDUN Technologies, Zurich, Switzerland
Intern, 2017
Supported co-founders as first outside
hire to build a strong business foundation.
Influenced key strategic decision to
pivot from B2C to B2B. Analyzed clinical
market (segmentation, competitor
analysis) for business plan definition.
Built pitch decks for startup contests
and investor presentations.
Alexis M. Saucy
Swiss Federal Institute of Technology (ETH)
Zurich, Zurich, Switzerland
B.Sc., Health Sciences and Technology, 2016
M.Sc., Neuroscience, 2018
An opportunity to build and grow
healthcare services companies
Geode Health, Chicago, IL
MBA Intern, Summer 2023
My summer project focused on
transitioning providers from salary-
based compensation to pay based on
productivity.
MyEyeDr, Vienna, VA
Senior Associate, Strategic Initiatives,
2021-2022
Developed strategy for launching 3 new
service lines, forecasted to generate
~$30M in incremental revenue at run-rate.
Established co-marketing partnership
with health-insurance brokerage.
Conducted due diligence of e-commerce
eyewear retailer and telehealth company.
Bain & Company, Atlanta, GA
Senior Associate Consultant, 2020-2021
Associate Consultant 2018-2020
Example projects include: commercial
due diligence for private equity firms as
part of Bain’s Private Equity Group,
merger integration for a large physician
group, merger integration for an industrial
distributor, technology strategy and
performance improvement for a
property & casualty insurance company.
TJ Schmidt
University of North Carolina, Chapel Hill, NC
B.S., Business Administration, B.A., Computer
Science, 2018
An opportunity to design and develop
innovative medical devices that transform
patient outcomes.
Cerebral Surgical, Philadelphia, PA
Co-Founder, 2023
Founded a medical device company
specializing in the development of an
innovative surgical tool aimed at
enhancing the efficiency, safety, and
cost-effectiveness of shunt procedures.
Spearheaded engineering and proto-
typing phases, driving the evolution of
the product from concept to tangible
prototype. Fostered strategic
collaborations with top-tier medical
device product development firms.
Directed company financials by
overseeing budgeting and timelines,
ensuring resource allocation was in
alignment with strategic goals and
milestones. Played an instrumental role
in the intellectual property aspects of
the venture, reviewing proposals and
leading the patent submission process.
Longeviti Neuro Solutions, Baltimore, MD
Senior Biomedical Engineer, 2018-2022
Invented novel imaging technology
that screens for brain tumors safely and
quickly. Augmented brain-machine-
interface technology to benefit
quadriplegics. Led development of
wireless brain mapping implant that
treats patients suffering from chronic
seizures. Developed an efficient manu-
facturing process for cranial implants.
Led a 4-member team to develop
accelerated aging tests of reconstructive
implants. Implemented computer
simulations for functional brain
implants to demonstrate their safety
for in-human use.
Jimmy A. Shah
Georgia Institute of Technology, Atlanta, GA
B.S., Biomedical Engineering, Highest Honors,
2018; Emory University, Atlanta, GA
B.S, Biology, 2016
25
An opportunity to work at the intersection
of science, technology, and business to
catalyze the development of innovative
biotherapeutics and medical products.
Seismic Therapeutic, Cambridge, MA
Business Development Intern, Summer 2023
Conducted scientific diligence on
extracellular protein degradation assets
through review of pre-clinical and
clinical data to compare PK/PD, immuno-
genicity, dosing regimens and efficacy.
Barclays Investment Bank,
New York, NY
Healthcare M&A Summer Associate,
Summer 2023
Analyzed M&A opportunities for small
and mid-cap biotechnology companies
by conducting strategic due diligence
and valuations of clinical pipeline assets.
Valar Labs, Palo Alto, CA
Computational Pathology Product Lead, 2022
Developed AI-based diagnostic algorithms
that leverage histopathology images of
solid tissue tumor specimens to generate
biomarkers for predicting risk of post-
treatment cancer recurrence; co-authored
abstract presented at ASCO GI 2023.
Foundation Medicine, Cambridge, MA
Product Manager, 2019-2022
Led cross-functional teams of software
engineers, data scientists, and cancer
researchers to develop regulatory-grade
genomic datasets and software platforms
for use by academic researchers and
biopharma R&D units for drug discovery
and clinical development.
McKinsey & Company, Jersey City, NJ
Business Analyst, 2017-2019
Supported clients across life sciences,
medical devices, and public sector
practices with R&D portfolio prioritization,
M&A due diligence, manufacturing
strategy, commercial forecasting and
launch strategy, and clinical evidence
generation.
Kunal J. Shah
Columbia University, New York, NY
B.A., Cum Laude, Biology, 2017
An opportunity to invest in, operate
and build market-leading healthcare
services companies.
The Sterling Group, L.P., Houston, TX
Vice President, Private Equity Investment
Intern, Summer 2023
Conducted due diligence for two buyout
deals, leading all aspects, including
business/financial due diligence, financial
modeling, market survey, and third-party
advisors’ supervision. Assisted in deal
negotiations and structure.
Sagana, Remote
Investment Management Intern,
Summer 2022
Developed healthcare services investment
thesis by interviewing 40+ founders
and co-investors. Led industry/business
diligence and presented $5M elderly care
business deal to investment committee.
Pristyn Care, Gurgaon, India
Head of Business, 2020-2022
Launched kidney treatment services
business, managing a 70-member
team, generating $4M/year. Prepared
valuation and elective surgeries industry
analysis for Pristyn’s $50M Series D
fundraise and led negotiations for a
$100M competitor acquisition of a
primary care provider.
Schlumberger, India, UAE, Malaysia, Russia
Client Engagement Coordinator, 2014-2020
Advised senior clients and India
Petroleum Ministry on nation’s energy
outlook. Managed team of 50+ engineers
across India, Bangladesh, Nepal,
Malaysia, Thailand. Recommended
optimal capital allocation solutions to
India’s largest public sector energy
company to invest in offshore assets,
driving 2.5x P/E ratio increment.
Awarded “Claude Boyeldieu Prize for
Business Relevance” by Schlumberger
VP Operations.
Lovely Sharma
Indian Institute of Technology (IIT ISM),
Dhanbad, India
B.Tech., Petroleum Engineering, 2014
An opportunity to partner with and
build large-scale, low-cost healthcare
solutions for the developing world.
Annalise.ai, Remote
Commercial Intern, Summer 2023
Worked with a rapidly-growing
Australian company to bring AI solutions
in medical imaging to the US. Evaluated
potential market opportunities with
C-suite level stakeholders at large
radiology practices, focused on CT head
and CXR chest.
Spice Healthcare Private Limited,
Gurugram, India
CEO, 2020 – Present
Founded a $40M company focusing on
accessible and affordable diagnostic
solutions. Disrupted the COVID-19 testing
market by offering RT-PCR tests at an
80% price reduction by pioneering the
mobile-laboratory model in India.
Conducted over 7M tests, set up India’s
first mobile genome-sequencing and
mobile-pathology labs. Received
recognition like Bloomberg’s Global 50
‘Ones to Watch’ and the Business World
Young Entrepreneur of the Year award.
Currently bringing radiology AI solutions
to India through a similar model.
McKinsey & Company, Gurugram, India
Business Analyst, 2020-2020
Helped plant the seeds for an entrepre-
neurship unit within India’s leading
engineering university, organize events
such as Reimagining the Next Normal
for Asia & the World, and drive up sales
by over 20% for leading Indian retailers.
Avanee Singh
Stanford University, Stanford, CA
B.A., Psychology and Economics, 2018
M.A., Public Policy, 2019
26
Nikkie B. Singh
University of California, Los Angeles, Los Angeles,
CA; B.S., Summa Cum Laude, Chemistry, 2018
An opportunity to help commercialize
innovative therapeutics and ensure
patients receive life-saving treatments.
Genentech, South San Francisco, CA
Commercial Marketing Intern, Summer 2023
Uncovered opportunities to capture
$55M in potential revenue upside
across an untapped customer segment.
Led cross-functional stakeholders in
development of targeted account plans
and defined role-specific responsibilities.
Spearheaded strategy to redesign
peer-to-peer engagement and speaker
programs in light of increasing regulations
and budget cuts. Synthesized cross-
therapeutic area insights and conducted
secondary research to inform potential
pilot programs.
Deloitte Consulting, Los Angeles, CA
Senior Consultant 2022
Consultant 2020-2022
Business Analyst, 2018-2020
Led development of implementation
plan for corporate strategy across
2500+ people organization. Created
tools for virtual, strategic decision-making,
facilitated executive workshops and
prepared C-suite deliverables to construct
5-year corporate strategy, including key
initiatives to reduce OpEx by >$100M.
Interviewed 30 oncologists, including
high-profile researchers and oncology
directors at top academic centers;
synthesized insights, identifying value
proposition and data needs to drive
treatment uptake for client’s small cell
lung cancer drug. Created database of
3500+ KOLs and conducted detailed
analyses for prioritization and influence
mapping of KOLs. Segmented $1.5B
rare disease market by patients and
physicians.
Joanna Ariel Skeath
University of Maryland, College Park, MD
B.S., Summa Cum Laude, Finance, 2011
Harvard University, Cambridge, MA
Masters in Public Administration, expected
May 2024
An opportunity to invest in and partner
with companies and management
teams to improve cost, access, and
quality for healthcare and education
globally.
BPEA EQT, Hong Kong SAR/Los Angeles,
CA U.S.
Summer Vice President, 2023
Assessed cross-border investment
opportunities in healthcare (clinical trial
services), education (ed tech and
education services), and consumer
(pet products), with a focus on APAC.
Performed market assessment, financial
analysis, and preparation of materials
for in-person meetings with target
company’s CEO.
LLR Partners, Philadelphia, PA U.S.
Investment Professional, 2021-2022
MBA Intern, 2020-2021
Evaluated investments in healthcare
and education technology. Led investment
theses in clinical trial technology and
provider supply chain, resulting in two
closed deals (RealTime CTMS, VPL). Led
key diligence workstreams (market
assessment, financial / operational
analyses, preparation of IC and
management meeting materials,
oversight of third-party vendors).
The Boston Consulting Group
Consultant, 2018
Associate, 2015-2017
Served strategy consulting clients
across healthcare, technology, education,
and PE diligence. Select healthcare
experience includes retail pharmacy
(national roll-out of data-driven patient
outreach to boost adherence) and med
tech (market study for potential Latin
America launch of novel affordable
arbovirus diagnostic device).
Nick Skerritt
University of Sydney, Sydney, Australia
BComm (Liberal Studies), Finance, Accounting,
Business Information Systems, 2017
An opportunity to meaningfully bend the
curve of significant global population
health challenges through innovative
interventions with best-in-class science.
Flik Therapeutics, Philadelphia, PA
Co-founder, 2023-Present
Co-founded an early-stage biopharma
developing a prescription therapeutic
to help people quit smoking and vaping.
Developed key therapeutic features
across drug delivery device and digital
therapeutic, in consultation with
nationally recognized addiction medicine
experts. Raised Seed financing from
senior industry leaders, including
co-founder of Spark Tx, Jeff Marrazzo.
Identified and negotiated multi-million
dollar contracts with product design
firm and other consultants.
Pathways Residences, Sydney, Australia
Head of Strategy and Corporate
Development, 2022
Sourced and led joint venture
(incl. equity investment) partnership for
$250M integrated seniors living/nursing
home. Led investment committee and
building of business case, directly
negotiated all transaction documentation,
managed 5 diligence teams.
Ernst & Young Investment Banking
team, Sydney, Australia
Manager, 2018-2022
Managed sell- and buy-side M&A deals
within EY’s Investment Banking team,
primarily focused on middle market
healthcare and sponsors transactions.
Early promoted to Manager in 6 months
(in a normal 3-year promotion cycle).
Advised Quadrant Private Equity on its
~50% acquisition of Fullerton Health
Australia, a leading primary care provider.
27
James Soo, M.D.
Imperial College London, London, U.K.
B.Sc., Medical Sciences with Management,
1st Class Honors, 2015
M.D., Medicine, 2017
An opportunity to build and invest in
innovative biotechnology companies
that bring game-changing therapies
to patients.
Genentech, South San Francisco, CA
MBA Intern, Portfolio Strategy & Execution
(Planning), Summer 2023
Evaluated Phase 3 development options
for lead KRAS inhibitor program,
performing valuation analyses and
working cross-functionally to drive
risk-reward discussions. Conducted a
5-year retrospective analysis of oncology
strategy, delivering insights into portfolio
evolution and pinpointing areas for
potential team-specific learnings.
Lucence, Palo Alto, CA and Singapore
Manager, Clinical Development, 2020-2022
Developed clinical trials to validate liquid
biopsies for early cancer detection and
treatment selection including $2M
flagship prospective global multicenter
lung cancer trial. Drove competitor
analyses and collaborated with R&D
on biomarker panel development.
Spearheaded Medicare submission
and supported growth of commercial
operations in the U.S.
Cambridge University Hospitals,
Cambridge, U.K.
Physician, 2018-2020
Managed and admitted patients at a
leading academic tertiary care center as
well as community settings as part of
the 2-year UK national training program
(NHS) comprising rotations in internal
medicine and general surgery.
Samantha S. Spear
Brown University, Providence, RI
A.B., Biology, 2017
An opportunity to improve efficiency
and quality in healthcare delivery
through technology and innovation.
Manatt Health Strategies, New York, NY
Summer Analyst, Summer 2023
Conducted research and data analysis,
developed materials and communicated
with clients across projects on topics
including Long-Term Supports & Services
(LTSS), state-based insurance marketplaces,
Mental Health Parity Policy, county-level
data exchange infrastructure and 1115
Medicaid waiver requirements for
psychiatric bed-tracking tools.
Verana Health, New York, NY
Sr. Manager, Life Science Partnerships,
2021-2022
Manager, Life Science Partnerships,
2020-2021
Led project management and client
partnerships for the new clinical trials
business unit. Created and managed Site
Engagement Team including two direct
reports. Developed long-term strategy
road map for business unit, collaborating
with Product, Finance and executive
leadership teams to forecast.
TrialSpark, New York, NY
Client Growth Associate, 2019-2020
Supported commercial organization with
market sizing and segmentation studies,
deal cycle support and account
management. Improved deal conversion
rate by 80% in H1 2020 vs H2 2019.
Launched Project Covalence, a COVID-19
antibody surveillance study.
Guidepoint, New York, NY
Project Manager, 2018-2019
Research Manager, 2018-2018
Research Analyst, 2017-2018
Managed primary research projects
for consulting clients conducting due
diligence, strategy research and market
studies.
Maria Veronika
Stattin
Columbia University, New York, NY
B.A., Neuroscience and Behavior, 2019
An opportunity to be at the center
between science and business to
ensure that drugs which help patients
make it to the market.
Regeneron, Tarrytown, NY
Business Development intern,
Summer 2023
Conducted landscaping and prioritization
to acquire selected mechanism of
action for autoimmune indications.
Created deck to pitch internal molecule
to VCs for out-licensing. Analyzed
potential commercial landscape for
mAb in infectious disease, defining
Regeneron’s strategy in indication with
clinical development team. Defined
counterproposal for in-licensing of
preclinical assets in infective disease.
The Boston Consulting Group,
Milan, Italy
Senior Associate, 2022
Associate, 2019-2021
Core member of health care practice
focused on pharma and biotech.
Relevant Project work: Devised consumer
health care portfolio strategy for top 3
Italian biopharma company, leading to
private acquisition of the largest
European topical analgesics patches
manufacturer. Developed biotech
portfolio strategy for rare disease
franchise for leading Italian pharma
company, focusing on pipeline for gene
therapy, gene editing ex vivo and RNA
therapeutics, leading to partnership
with Moderna. Analyzed outside-in
potential business plan of over 10
assets in rare diseases and created a
methodology currently used across BCG
projects in Italy, during due diligence of
one of top 5 Italian pharma companies.
28
David L. Wang
Harvard University, Cambridge, MA
A.B., Stem Cell and Regenerative Biology, 2016
An opportunity to invest in or be a
product leader for innovative healthcare
services companies focused on improving
outcomes.
Peloton Equity, Greenwich, CT
Summer Associate, Summer 2023
Supported ~$100M growth
recapitalization bid for DME revenue
cycle platform. Owned valuation model
and conducted financial diligence with
management team and QoE auditor.
Presented thesis on investable telehealth
opportunities and prioritized deal
targets to partners.
Meta, New York, NY
Strategy and Operations Manager —
Health Technology, 2021-2022
Spearheaded product roadmapping for
hearing loss accessibility feature on AR
glasses with research engineers and
clinical audiologists. Defined GTM strategy
in health insurer and D2C consumer
channels and co-created PRD for
hypertension management feature on
wrist as part of new product launch
planning. Led team of analysts in
estimating potential impact of that
feature through analysis of 500M+
medical claims.
McKinsey & Company, New York, NY
Senior Associate, 2018-2021
Increased daily COVID-19 testing vol-
ume ~900% for state government by
developing population testing strategy
and operationalizing community testing
sites with National Guard teams.
Modeled vaccine supply to guide
prioritization strategy and operationalize
provider sites in early 2021. Supported
seven M&A due diligences on healthcare
services assets for private equity mega-
funds. Embedded with senior leaders at
leading academic hospital with ~$9B
patient service revenue to develop 10%
margin improvement strategy.
Jonathan J. Wakim
University of Florida, Gainesville, FL
B.A., Cum Laude, Economics, 2018
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA M.D.
Candidate, 2024
An opportunity to combine my clinical
acumen with business expertise to
innovate in healthcare delivery using
emerging technologies.
LionBird Ventures, New York, New York
Summer Associate, Summer 2023
Performed initial review and triage of
inbound deal flow of >500 start-ups
and performed due diligence on SaaS
digital health investment opportunities
for preparation of investment memos
for LPs. Leveraged medical knowledge
in pitch meetings to assess start-up
candidacy to receive investments of
$500,000 - $5M in seed and Series A
funding. Led development of portfolio
CRM platform to monitor portfolio
companies and automate tracking of
incoming deals.
Rock Health Capital, Remote
Venture Fellow, 2022-2023
Conducted due diligence on digital
health companies spanning infrastructure,
digitization of life sciences, and
tech-enabled services. Supported in the
execution of 2 deals including writing
of investment memos to LP base.
Responsible for monthly portfolio
management and deal flow generation
summaries for LPs.
Luke Thompson
University of Georgia, Athens, GA
B.A., Economics 2017
Investing in healthcare companies.
Marshall Wace, New York, NY
Investment Analyst, Summer 2023
Developed and presented investment
recommendations.
Staple Street Capital, New York, NY
Private Equity Associate, 2018-2022
Evaluated acquisitions across industries, led
diligence, navigated complex transactions.
Citi, New York, NY
Investment Banking Analyst, 2017-2018
Advised healthcare companies on mergers,
acquisitions, and IPOs.
29
Kristin N. Wong
Stanford University, Stanford, CA
B.A., Human Biology, 2017
An opportunity to develop and scale
innovative technologies to improve the
delivery of health care.
Amazon, Seattle, WA
Senior Product Manager Intern, 2023
Developed product strategy for global
Prime member acquisition, focused on
enhancing benefit awareness and value
proposition for Non-Prime customers
across online retail journey. Collaborated
with 20+ stakeholders across regions
(e.g., North America, Europe, Asia) and
functions (e.g., UX, engineering,
finance) to evaluate customer pain
points, business needs and technical
feasibility, informing prioritization of
product initiatives.
ZS Associates, San Mateo, CA
Associate Consultant, 2020-2022
Associate, 2017-2019
Partnered with pharmaceutical clients
by leading qualitative and quantitative
market research with providers and
patients to inform business develop-
ment and commercialization decisions.
Analyzed customer insights (e.g., drivers
and barriers to adoption, unmet needs),
market performance data and competitive
landscape to develop data-driven strategic
recommendations for launching and
scaling products, including the first
FDA-approved treatment for COVID-19,
the market-leading treatment for HIV
and a mobile health app to help
patients adhere to medication.
Executed workshops for 40+ global
cross-functional clients to brainstorm
strategies to respond to competitive
threats, achieving organizational alignment
around contingency planning.
Kerone Wint, MD
University of the West Indies, Mona, Jamaica
Bachelor of Medicine and Surgery, Honors, 2014
B.S., Honors, Basic Medical Sciences, 2012
An opportunity to innovate scalable
healthcare solutions that benefit under-
served and vulnerable populations.
McKinsey & Company, San Francisco, CA
Associate Intern, Summer 2023
Life Sciences practice—prepared for
launch of first-in-class therapy.
Conducted expert interviews; designed,
implemented and analyzed a 100+
respondent survey. Refined clinical
messages, developed a claims library
and developed the messaging strategy
presented to the CEO. SHaPE practice—
developed an integrated (medical and
social services) value-based care model
project demonstration targeting a
high-need, high-cost Medicaid-eligible
population for a not-for-profit client,
presented to philanthropists and
approved for implementation.
Kingston Public Hospital, Bustamante
Hospital for Children and National
Chest Hospital, Kingston & St Andrew,
Jamaica
Plastic Surgery Medical Officer II, 2016-2022
Performed 700+ major and minor
plastic surgery procedures. Supervised
and trained junior staff. Supervised
minor operating theater lists and
responsible for in-hospital management
of 200+ patients per year. Served on
hospital-level committees.
South East Regional Health Authority,
St Catherine, Jamaica
Senior House Officer and Medical Intern,
2014-2016
Assisted in surgical operations across
general surgery, obstetrics and gynecology,
and plastic surgery rotations. Also
completed rotations in internal medicine,
pediatrics, and community health.
June Wang
Barnard College, New York, NY
B.A., Economics and Political Science, 2014
An opportunity to build or invest in
companies that improve quality of care
or solve unaddressed patient, provider,
or caregiver needs.
Amazon, Seattle, WA
Senior Product Manager Intern, Summer 2023
Established $4M cost saving process to
manage alternative payment products.
Assembled dashboard that enables
~125-member team to monitor product
results. Partnered with Machine Learning
to implement customer friction reduction
solution to save $1.3M.
Medtronic, Boston, MA
Principal Associate, Venture Capital Team,
2021-2022
Senior Associate, Venture Capital Team,
2018-2021
Led due diligence of 20+ healthcare
technology companies and assessed
investment attractiveness via product
evaluations, expert interviews, market
research, and clinical data analysis. Pitched
investment committees on deal rationale
and terms to secure approval for 7+
investments. Supported 2 portfolio
companies as Board observer.
Criteo, New York, NY
Finance Business Partner
Conducted market sizing exercise with
Product and Sales team to identify new
product opportunities. Crafted business
case that led to development of new
product growing at 120% year over year.
BMO Capital Markets, New York, NY
Investment Banking Analyst, Healthcare Team
Executed ~$500M in M&A and capital raising
transactions by researching industry trends,
building financial models and valuation
analysis, and leading cross-functional
project teams.
30
Annie Xu
Yale University, New Haven, CT
B.A., Psychology & Economics, 2018
School of Social Policy and Practice at the
University of Pennsylvania, Philadelphia, PA
M.S.W. Candidate, 2024
An opportunity to design ventures that
deliver improved wellness and behavioral
health outcomes.
Pairfect, Philadelphia, PA
Founder, 2022-present
Launched startup focused on delivering
an authentic alternative to dating apps
through growing a network of matchmakers
to meet with each user. Awarded cash prizes
from Startup Challenge, VIP-X accelerator,
VIP Innovation Fund and consumer start-up
competition sponsored by Contrary and
Maveron.
Genoa Telepsychiatry, part of Optum,
Remote
Chief of Staff, 2021-2022
Created proposal on how to integrate
telepsychiatry capabilities within Optum’s
behavioral health vision. Designed new
pricing options of current services to
increase accessibility of telepsychiatry
programs to clinic partners. Led workshops
to enhance collaboration between clinic
and provider partnership teams.
The Boston Consulting Group,
Philadelphia, PA
Consultant, 2020-2021
Associate, 2018-2020
Strategy consultant for healthcare and public
sector organizations. Select experiences:
developed COVID response for public sector
organization’s sales team, led negotiation
between public sector client against
Fortune 50 competitor and designed
change management strategy for large
healthcare organization.
Rainbow (Laan)
Yeung
Harvard University, Cambridge, MA
B.A., Molecular and Cellular Biology, 2019
An opportunity to improve healthcare
access, transparency, and equity for
underserved or vulnerable patient
populations.
Menlo Ventures, San Francisco, CA
MBA Intern, Summer 2023
As a part of the Labs team, researched
opportunities in women’s health,
electronic health records, and the
resale economy. Supported work with
Future Founders and existing Labs
companies’ operations.
Odyssey Notebooks, Bethesda, MD
Founder, 2021-2023
Created fine paper products for
fountain pen users; 30,000+ units sold
worldwide. Awarded cash prizes from
Startup Challenge, VIP-X accelerator,
Innovation Fund, and Global TiE
University Pitch Competition.
McKinsey & Company, Boston, MA
Business Analyst, 2019-2021
Dedicated to McKinsey’s life sciences
and public health practices. Designed
cross-functional commercialization
process for COVID-19 vaccine and
managed rollout, overseeing supply
and allocation strategies. Established
Small Business Strong, state-based
non-profit to provide small businesses
professional resources. Created go-to-
market entry strategies for med tech
company, enabling 10x expansion of
operational capacity while maintaining
95%+ patient satisfaction.
31
The following organizations
provided internships for Health
Care Management Students in
Summer, 2023.
ACRE VENTURE PARTNERS
Los Angeles, CA
ADITUM BIO
San Franscisco, CA
AMAZON
Seattle, WA
ANNALISE.AI
Remote
ASTRAZENECA
Wilmington, DE
AUTHOR HEALTH
Philadelphia, PA
AWARE RECOVERY CARE
Philadelphia, PA
BARCLAYS
New York, NY
BIONTECH
Cambridge, MA
BOSTON CONSULTING GROUP
Philadelphia, PA & Seattle, WA
BPEA EQT
Hong Kong
CAREGIVER, INC.
Remote
CEREBRAL SURGICAL
Remote
CLEARVIEW
New York, NY
CLEARVIEW/PARTNERS
New York, NY
CRANEMERE GROUP
New York, NY
DAVITA
Remote
ELEMENT3 HEALTH
Remote
ELI LILLY
Indianapolis, IN
ELION HEALTH
Remote
FOODSMART
Remote
GENENTECH
South San Francisco, CA
GENERAL ATLANTIC
New York, NY
GEODE HEALTH
Remote
GOLDMAN SACHS
New York, NY
GUGGENHEIM PARTNERS
New York, NY
HEALTHMAP SOLUTIONS
Remote
HOSPITAL OF UPENN
Philadelphia, PA
HUMANA
Remote
J.P. MORGAN
New York, NY
JUXTAPOSE
New York, NY
LIONBIRD VENTURES
Remote
MANATT HEALTH
New York, NY
MARSHALL WACE
New York, NY
MCKINSEY
New York, NY, Chicago, IL &
San Francisco
MEDTRONIC
Minneapolis, MN
MENLO VENTURES
Remote
MORGAN STANLEY
San Francisco, CA
MTS HEALTH PARTNERS
New York, NY
NEMA HEALTH
Remote
NEUROFLOW
Philadelphia, PA
NYX PARTNERS
New York, NY
OSHI HEALTH
Remote
OXEON VENTURE STUDIO
New York, NY
PATINA HEALTH
Philadelphia, PA
PELOTON EQUITY
New York, NY
PENN MEDICINE
Philadelphia, PA
PFIZER
New York, NY
REGENERON
Tarrytown, NY
ROUTE
Remote
RTW INVESTMENTS
New York, NY
STARTUP
Remote
SWINERGY
Minneapolis, MN
T. ROWE PRICE
Baltimore, MD
TAIWAN MOBILE
Taiwan
THE STERLING GROUP
Houston, TX
THERMO FISHER SCIENTIFIC
Boston, MA
VERTEX
Boston, MA
WINDHAM VENTURE PARTNERS
New York, NY
Internship Sponsors
2023
ERIKA H. JAMES, PH.D.
Dean, The Wharton School
NICOLAJ SIGGELKOW, PH.D.
Vice Dean and Director, The Wharton Graduate Division
GUY DAVID, PH.D.
Chair, Health Care Management Department,
The Wharton School
JUNE M. KINNEY, M.A.
Director, MBA Program in Health Care Management
REBECCA VOLD
Administrative Coordinator,
MBA Program in Health Care Management
JANICE SINGLETON
Administrative Coordinator,
MBA Program in Health Care Management
Administration
32
Mentors are leaders and senior
managers in the health care field
who have agreed to provide career
and professional development
advice and guidance to Health Care
management students
TIM ABBOT
Zenyth Partners
Great Neck, NY
DAVE ALLEN
Medtronic
Minneapolis, MN
JOE ANDERSON
Nautic Partners
Boston, MA
ALEX APTEKMAN
360 Behavioral Health
Los Angeles, CA
HEATHER ASPRAS
Merck & Co
Philadelphia, PA
DANIEL ASTRACHAN
Discover Health
Wayland, MA
GRAHAM ATTIPOE
Tekla Capital Management
Boston, MA
TOBY AUWERTER
Endeavour Vision
Minnetonka, MN
MATT BAKER
Cortec Group
New York, NY
GEOF BAKER
Versational
Henderson, NV
VIKRAM BAKHRU, MD
Innovista Health Solutions
Los Angeles, CA
JOHN BARBIERI
Brigham and Women’s Hospital
Boston, MA
ALI BEHBAHANI, MD
New Enterprise Associates
Chevy Chase, MD
SIGAL BENARI
Medtronic
Sacramento, CA
LUKE BETTERMAN
Bain & Company
Seattle, WA
DARREN BLACK
Summit Partners
Boston, MA
SHANE BOUCHARD
Ensoma
Boston, MA
DAVID J. BRAILER
Cigna
Bloomfield, CT
KARA BROTEMARKLE
Roche / Genentech
Stockholm, Sweden
DAVID BROWER
Accent Therapeutics
Lexington, MA
JAMES BUXTON
New Enterprise Associates
New York, NY
EDWARD CHAN
1315 Capital
Philadelphia, PA
ARIANA CHEHRAZI
InterWell Health
Palo Alto, CA
BRIAN G. CHOI
The George Washington University
Washington, DC
BRETT CHUNG
AllStripes
San Francisco, CA
BRETT COHEN
Sevita
Boston, MA
CHASE CULBERTSON
Ridgemont Equity Partners
Charlotte, NC
SIDDHARTH DAMANIA
Medtronic
Nashville, TN
DAVID DENNIS
Cardinal Health
Dublin, Ohio
PITOU DEVGON
Velano Vascular
Philadelphia, PA
BENJAMIN DORANZ, PH.D
Integral Molecular
Philadelphia, PA
J. PATRICK DOUGHERTY
Beech Street Advisors
Philadelphia, PA
DEAN DRIZIN
BAYADA Home Health Care
Pennsauken, NJ
RAMI ELGHANDOUR
Arcellx
Redwood Shores, CA
MING FANG
Redmile Group
San Francisco, CA
BRENTON FARGNOLI, MD
AlleyCorp Healthcare
New York, NY
AILEEN FERNANDES
Arcellx
Redwood City, CA
KRISTIN FONG
Janssen R&D
San Francisco, CA
DANIKA FRY
Morgan Stanley
New York, NY
MICHAL GATTNAR
Pavis Capital
Mill Valley, CA
MICHAEL GAWLIK
New Mountain Capital
New York, NY
JIN GE
UCSF
San Francisco, CA
TORY GENTRY
Atrium Health Wake Forest Baptist
Winston Salem, NC
DAN GEOFFRION
DaVita Inc.
Minneapolis, MN
NAVID GHARAVI
Varsity Healthcare Partners
Los Angeles, CA
EVAN GIBSON
Neumora Therapeutics
Boston, MA
ANDY GLOWALLA
Cedars-Sinai Health System
Los Angeles, CA
NOAH GOODMAN
Chroma Medicine
Cambridge, MA
VIKAS GOYAL
Self Employed
Somerville, MA
TODD GUREN
Alignment Healthcare
Orange, CA
ALISON HAGAN
Deloitte Consulting
San Francisco, CA
TAEJIN JUSTIN HAM
ILIAS Biologics, Inc.
South Korea
LISA V. HARKNESS
McKinsey & Company
Stamford, CT
JOHN HARROFF
H.I.G. Capital
New York, NY
PHIL HEIFETZ
Innovative Supply Solutions LLC
Southampton, PA
LINDSAY HERMAN
UCLA Health
Los Angeles, CA
MATT HINCHEY
Evio Pharmacy Solutions
Denver, CO
VIVIEN HO
Pear VC
San Francisco, CA
VLAD HOGENHUIS
Chimera Bio
San Francisco, CA
SAM HOLLIDAY
Oshi Health
New York, NY
SHUBHRA JAIN
Tarsadia Investments
Newport Beach, CA
MUDIT K. JAIN
Treo Ventures
Santa Clara, CA
Health Care Program Mentors
2023
33
TODD JERLES
Trivest Partners
Coral Gables, FL
PANKAJ JETHWANI
W Health Ventures
Boston, MA
SAM KAHN
Blackstone
New York, NY
BEN KATZ
Happy Head, Inc.
Los Angeles, CA
REENA KERSCH
Deloitte Consulting
Herndon, VA
MIKE KIJEWSKI
MedCrypt
Solana Beach, CA
JOHN KIM
Y-mAbs Therapeutics
New York, NY
ANDI KLESTADT
Vanna Health
New York, NY
LISA A LACASSE
American Cancer Society
Cancer Action Network
Washington, DC
LETICIA LAZARIDIS GOLDBERG
Harmony Analytics
Atlanta, GA
ADAM LESSLER, MD
Evidity Health Capital
New York, NY
SCOTT LEVER
Teladoc Health
Purchase, NY
WENDY LIU
Pfizer Inc.
New York, NY
J.C. LOPEZ, MD
New Enterprise Associates
Chevy Chase, MD
GABE LUFT
Amulet Capital Partners
Greenwich, CT
DEREK LUKIN
Oliver Wyman
New York, NY
ROMAN MACAYA
Harvard T.H. Chan School of
Public Health
Boston, MA
REBECCA MADSEN
United Healthcare
New York, NY
JOSH MAGID
Evercore
New York, NY
HARI MAHADEVAN
Self Employed
Princeton, NJ
ANKIT MAHADEVIA
Spero Therapeutics
Cambridge, MA
RAVI MAHADEVIA
Summit Partners
Los Angeles, CA
JULIE MCCOMISH
Providence
Seattle, WA
ROBERT C. MCDONALD, MD
Aledo Consulting, Inc.
Indianapolis, IN
MARC MILLER
Universal Health Services
King of Prussia, PA
PHILIP MISHKIN
Komodo Health
New York, NY
DAN MULREANY
BridgeBio
San Francisco, CA
REGAN MURPHY
Oak Street Health
Chicago, IL
WESLEY NURSS
Jubatus Group
Fresno, CA
SHAINA OAKE
A2 Biotherapeutics
Los Angeles, CA
NORMAN PAI
Health Verity
Seattle, WA
BRANDON PANG
BCG
New York, NY
ARPAN PARIKH
The Collective
Los Angeles, CA
PAUL PARK
Circle Pharma
South San Francisco, CA
MITESH PATEL
Ascension
Philadelphia, PA
NIYOSHI PATEL
BeiGene
New York, NY
LIZ PECAN
Dispatch Bio
Philadelphia, PA
CHRISTIAN PEÑA
AssuranceSD, Inc.
Dana Point, CA
LISA PERLMUTTER
Health Hospitality Partners
Pittsburgh, PA
GIULIA PETERLONGO
DaVita, Inc.
Denver, CO
MICHAEL PETERSON
McKinsey & Company
Dallas, TX
CARY PFEFFER, MD
Third Rock Ventures
Boston, MA
DAVID PINKERT
Friday Health Plans, Inc.
Denver, CO
LEN PODOLSKY
EverVet Partners
Conshohocken, PA
BRIAN POWL
FateTherapeutics
San Diego, CA
JON MICHAEL REESE
General Atlantic
New York, NY
AMIR REICHMAN
BiondVax Pharmaceuticals
Jerusalem, Israel
CHARLIE ROBINSON
Hand in Hand Health
Los Angeles, CA
FRED RONNAU
N1Health
Franklin Lakes, NJ
BEN ROOKS
ST Advisors
Sonoma, CA
CAROLYN LYN SALSGIVER KOBSA
Yale New Haven Health System
New Haven, CT
MATT SCHULZ
The Vistria Group
Chicago, IL
SUSAN SERRANO
bluebird bio, Inc.
Concord, MA
JONATHAN SHANNON
LexisNexis Risk Solutions
Santa Monica, CA
SHAFINA SHEHNAZ
United Health Group
Minnetonka, MN
ANNE SISSEL
Baxter Healthcare
Deerfield, IL
HEIDI SPRANG
Akebia Therapeutics
Brookline, MA
MEIR STEIN
OrCam
Israel
ROSS STERN
Summit Partners
Boston, MA
JOSHUA TALBOT
McKinsey & Company
Salt Lake City, UT
MARINA TARASOVA
Paloma Health
New York, NY
FERNANDO TORRES
CarepathRx, LLC
Atlanta, GA
MAYA TSUKERNIK
Janssen R&D
New Brunswick, NJ
NINA UNDERMAN
Humana
Cambridge, MA
JOHN URQUHART
HealthCare Royalty Partners
Boston, MA
REED VAN GORDEN
Deerpath Capital
Chicago, IL
MICHAEL VIOLA
naviHealth
Wayne, PA
SARAH WEBER
Altium Capital Management
New York, NY
DAVID WILKINSON
Russell Street Ventures
Nashville, TN
DAN WOLSK
Claros Analytics
Princeton, NJ
MO YANG
GI Partners
San Francisco, CA
DANIEL YIP
Madrigal Pharmaceuticals
West Conshohocken, PA
DEREK YUAN, MD
Zai Lab
Palo Alto, CA
QUINGAN ZHOU
Included Health
Durham, NC
THOMAS C. ZIPP
Halozyme Therapeutics, Inc.
Malvern, PA
KEELY ZIPP
iOnctura SA
Malvern, PA
34
The Program Faculty are drawn from the
Wharton School, the School of Medicine,
the School of Nursing, and the School
of Arts and Sciences at the University of
Pennsylvania. Executives from leading health
care organizations teach courses and serve
as guest lecturers in the Program as well.
Additional support is provided by the Fellows
and Associates of the Leonard Davis Institute
of Health Economics
SRINATH ADUSUMALLI, M.D.
Adjunct Professor of Health Care
Management, The Wharton School
DIANE ALEXANDER, PH.D.
Assistant Professor, Health Care
Management, The Wharton School
ABBY E. ALPERT, PH.D.
Assistant Professor, Health Care
Management, The Wharton School
DAVID A. ASCH, M.D., M.B.A,
Senior Vice Dean for Strategic Initiatives,
Perelman School of Medicine; Professor of
Medicine, Perelman School of Medicine at
the University of Pennsylvania; Professor,
Health Care Management, The Wharton
School
ALON BERGMAN, PH.D.
Assistant Professor, Department of
Medical Ethics & Health Policy, Perelman
School of Medicine, University of
Pennsylvania, Assistant Professor of Health
Care Management, The Wharton School
LAWTON R. BURNS, PH.D., M.B.A.
James Joo-Jin Kim Professor of Health Care
Management, The Wharton School;
Faculty Co-Director, Roy and Diana
Vagelos Program In Life Sciences
& Management
MOLLY CANDON, PH.D.
Research Assistant Professor, Center for
Mental Health, Department of Psychiatry,
Perelman School of Medicine,
Assistant Professor of Health Care
Management, The Wharton School
PATRICIA M. DANZON, PH.D.
Celia Z . Moh Professor Emeritus
of Health Care Management,
The Wharton School
GUY DAVID, PH.D.
Chair, Health Care Management
Department, and Director, Health Care
Management Program, The Wharton
School; Alan B. Miller Professor, Health
Care Management, The Wharton School
PITOU DEVGON, M.D., M.B.A.
Advisor and Investor; Lecturer, Health Care
Management, The Wharton School
BENJAMIN DORANZ, PH.D., M.B.A.
President and CEO, Integral Molecular
Senior Fellow, Health Care Management,
The Wharton School
EZEKIEL J. EMANUEL, M.D., PH.D.
Diane v .S . Levy and Robert M .Levy
University Professor and Vice Provost for
Global Initiatives; Professor, Health Care
Management, The Wharton School
HANMING FANG, PH.D.
Professor of Economics, University of
Pennsylvania, Professor, Health Care
Management, The Wharton School
BRADLEY M. FLUEGEL
Advisor; Lecturer, Health Care
Management, The Wharton School
DAVID GRANDE, M.D.
Associate Professor of Medicine, Perelman
School of Medicine, Associate Professor of
Health Care Management, The Wharton
School
ATUL GUPTA, PH.D.
Assistant Professor, Health Care
Management, The Wharton School
SCOTT E. HARRINGTON, PH.D.
Alan B. Miller Professor Emeritus of Health
Care Management and Business
Economics and Public Policy,
The Wharton School
JOHN C. HERSHEY, PH.D.
Anheuser-Busch Professor Emeritus of
Management Science; and Health Care
Management, The Wharton School
JOHN KIMBERLY, PH.D.
Henry Bower Professor Emeritus, Health
Care Management, The Wharton School
MARISSA KING, PH.D.
Alice Y. Hung President’s Distinguished
Professor, Professor of Health Care
Management, The Wharton School
JUNE M. KINNEY, M.A.
Director, Graduate Program in Health Care
Management; Lecturer, Health Care
Management, The Wharton School
GARY J. KURTZMAN, M.D.
Managing Director, Prostasia Health;
Lecturer, Health Care Management,
The Wharton School
JOAN LAU, PH.D.
Adjunct Professor of Health Care
Management in the Associated Faculty
of the Wharton School
RISA LAVIZZOMOUREY, M.D., M.B.A.
Robert Wood Johnson Foundation
Population Health and Health Equity
Professor Emeritus
CLAUDIO LUCARELLI, PH.D.
Associate Professor, Health Care
Management, The Wharton School
JEFFREY P. LIBSON, J.D.
Partner, Cooley; Lecturer, Health Care
Management, The Wharton School
HARI MAHADEVAN, PH.D.
Independent Consultant; Senior Fellow,
Health Care Management,
The Wharton School
AMOL NAVATHE, M.D., PH.D
Assistant Professor of Medical Ethics
and Health Policy, Perelman School of
Medicine, Assistant Professor of Health
Care Management, The Wharton School
INGRID NEMBHARD, PH.D., M.S.
Fishman Family President’s Distinguished
Associate Professor, Health Care
Management, The Wharton School
STEVEN A. NICHTBERGER, M.D.
Adjunct Professor and Senior
Fellow, Health Care Management,
The Wharton School
ALEXANDER OLSSEN
Assistant Professor, Health Care
Management, The Wharton School
MITESH S. PATEL, M.D., M.B.A.
Adjunct Professor of Health Care
Management, The Wharton School
MARK V. PAULY, PH.D.
John M. Bendheim, W’40 and Thomas L.
Bendheim, WG’90 Professor Emeritus of
Health Care Management
WILLIAM P. PIERSKALLA, PH.D.
Professor Emeritus
DOUGLAS A. PRESENT, M.B.A.
Investor and Advisor; Lecturer, Health Care
Management, The Wharton School
ARNOLD J. ROSOFF, J.D.
Professor Emeritus, Legal Studies
and Business Ethics; and Health Care
Management, The Wharton School
Faculty
35
STEPHEN M. SAMMUT, M.B.A., D.B.A.
Lecturer and Senior Fellow, Health Care
Management, Lecturer, Entrepreneurial
Programs, The Wharton School
JEFFREY H. SILBER, M.D., PH.D.
The Nancy Abramson Wolfson Professor of
Health Services Research, The Children’s
Hospital of Philadelphia; Director, Center
for Outcomes Research, The Children’s
Hospital of Philadelphia, Professor of
Pediatrics and Anesthesiology & Critical
Care, The Perelman School of Medicine,
Professor of Health Care Management,
Health Care Management, The Wharton
School
JEFFREY A. SOLOMON, M.D., M.B.A.
Acting Vice President of Clinical Affairs,
XACT Robotics, Lecturer Health Care
Management, The Wharton School
HUMMY SONG, PH.D.
Assistant Professor of Operations,
Information and Decisions, Assistant
Professor of Health Care Management,
The Wharton School
KEVIN G.M. VOLPP, M.D., PH.D.
Mark V. Pauly President’s Distinguished
Professor at Perelman School of Medicine
and Health Care Management at the
Wharton School, Chief, Division of Health
Policy, Director, Center for Health
Incentives and Behavioral Economics
RACHEL M. WERNER, M.D., PH.D.
Professor of Medicine, Perelman School of
Medicine at the University of Pennsylvania
School of Medicine; Professor, Health Care
Management, The Wharton School;
Executive Director, Leonard Davis Institute
for Health Economics
JOHN J. WHITMAN, M.B.A.
CEO, Chandler Hall Health Services;
Lecturer, Health Care Management,
The Wharton School
GUY DAVID, PH.D.
Chair, Health Care Management
Department, The Wharton School,
Alan B. Miller Professor, Health Care
Management, The Wharton School
JUNE KINNEY
Director, MBA Program
in Health Care Management
The Wharton School
The University of Pennsylvania
values diversity and seeks talented
students, faculty and staff from diverse
backgrounds. The University of
Pennsylvania does not discriminate
on the basis of race, sex, sexual
orientation, gender identity, religion,
color, national or ethnic origin, age, dis-
ability, or status as a Vietnam Era
Veteran or disabled veteran in the
administration of educational policies,
programs or activities; admissions
policies; scholarship and loan awards;
athletic, or other University adminis-
tered programs or employment.
Questions or complaints regarding
this policy should be directed to:
Executive Director,
Office of Affirmative Action
and Equal Opportunity Programs
Sansom Place East
3600 Chestnut Street, Suite 228
Philadelphia, PA 19104-6106
215.898.6993 (Voice)
215.898.7803 (TDD)
©2022, The Trustees of
the University of Pennsylvania.
All rights reserved.
Photography of students: adamgierkephotography.com
